Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
JR Vane
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Chemicals & Drugs
Living Beings
Physiology
Disorders
Anatomy
Phenomena
Sign-in to see full Profile
Network (preview)
56
Thiemermann, Christoph
22
Salvemini, Daniela
18
Botting, Regina
18
Corder, Roger
17
Szabó, Csaba
11
Sessa, William
9
Mollace, Vincenzo
8
Thomas, Roger
6
Akarasereenont, Pravit
5
Thiemermann, Christoph
5
Gross, Steven
5
Gryglewski, Ryszard
5
Fournier, Alain
3
Adams, GE
3
boughton-smith, nigel
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of JR Vane (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2004: Vane J R
Adventures and excursions in bioassay: the stepping stones to prostacylin.
Bioscience reports 2004;24(4-5):254-79.
-
2004: Smith Charles G; Vane John R
The discovery of captopril: a reply.
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2004;18(9):935.
-
2003: Vane J; Corin R E
Prostacyclin: a vascular mediator.
European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery 2003;26(6):571-8.
-
2003: Vane J R; Botting R M
The mechanism of action of aspirin.
Thrombosis research 2003;110(5-6):255-8.
-
2003: Smith Charles G; Vane John R
The discovery of captopril.
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2003;17(8):788-9.
-
2003: Vane John
The mechanism of action of anti-inflammatory drugs.
International journal of clinical practice. Supplement 2003;(135):2.
-
2002: Warner Timothy D; Mitchell Jane A; Vane John R
Cyclo-oxygenase-2 inhibitors and cardiovascular events.
Lancet 2002;360(9346):1700-1.
-
2002: Vane John R
Biomedicine. Back to an aspirin a day?
Science (New York, N.Y.) 2002;296(5567):474-5.
-
2001: Vane J R
My life and times with enzymes and mediators.
Medical science monitor : international medical journal of experimental and clinical research 2001;7(4):790-800.
-
2000: Vane J R
The fight against rheumatism: from willow bark to COX-1 sparing drugs.
Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 2000;51(4 Pt 1):573-86.
-
2000: Vane J R; Warner T D
Nomenclature for COX-2 inhibitors.
Lancet 2000;356(9239):1373-4.
-
2000: Ballou L R; Botting R M; Goorha S; Zhang J; Vane J R
Nociception in cyclooxygenase isozyme-deficient mice.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(18):10272-6.
-
2000: Vane J R; Botting R M
The future of NSAID therapy: selective COX-2 inhibitors.
International journal of clinical practice 2000;54(1):7-9.
-
2000: Vane J R
The mechanism of action of anti-inflammatory drugs.
Ernst Schering Research Foundation workshop 2000;(31):1-23.
-
1999: Vane J R
The history of inhibitors of angiotensin converting enzyme.
Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 1999;50(4):489-98.
-
1999: Warner T D; Giuliano F; Vojnovic I; Bukasa A; Mitchell J A; Vane J R
Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis.
Proceedings of the National Academy of Sciences of the United States of America 1999;96(13):7563-8.
-
1999: Simmons D L; Botting R M; Robertson P M; Madsen M L; Vane J R
Induction of an acetaminophen-sensitive cyclooxygenase with reduced sensitivity to nonsteroid antiinflammatory drugs.
Proceedings of the National Academy of Sciences of the United States of America 1999;96(6):3275-80.
-
1998: Vane J R; Botting R M
Anti-inflammatory drugs and their mechanism of action.
Inflammation research : official journal of the European Histamine Research Society ... [et al.] 1998;47 Suppl 2():S78-87.
-
1998: Vane J R
COX-2 inhibitors: background knowledge for clinical use. Introduction.
Inflammation research : official journal of the European Histamine Research Society ... [et al.] 1998;47 Suppl 2():S77.
-
1998: Vane J R; Botting R M
Mechanism of action of nonsteroidal anti-inflammatory drugs.
The American journal of medicine 1998;104(3A):2S-8S; discussion 21S-22S.
-
1998: Vane J R; Bakhle Y S; Botting R M
Cyclooxygenases 1 and 2.
Annual review of pharmacology and toxicology 1998;38():97-120.
-
1998: Vane J R; Botting R M
Mechanism of action of antiinflammatory drugs.
International journal of tissue reactions 1998;20(1):3-15.
-
1997: Vane J
Suppression of intestinal polyposis by inhibition of COX-2 in Apc knockout mice.
Japanese journal of cancer research : Gann 1997;88(11):inside front cover.
-
1997: Botting R; Vane J
Re-addressing relative selectivities.
Trends in pharmacological sciences 1997;18(9):312-3.
-
1997: Vane J R; Botting R M
Mechanism of action of aspirin-like drugs.
Seminars in arthritis and rheumatism 1997;26(6 Suppl 1):2-10.
-
1997: Higgs E A; Higgs G A; Moncada S; Vane J R
Prostacyclin (PGI2) inhibits the formation of platelet thrombi in arterioles and venules of the hamster cheek pouch. 1977.
British journal of pharmacology 1997;120(4 Suppl):439-43; discussion 437-8.
-
1997: Ferreira S H; Moncada S; Vane J R
Prostaglandins and the mechanism of analgesia produced by aspirin-like drugs. 1973.
British journal of pharmacology 1997;120(4 Suppl):401-12; discussion 399-400.
-
1997: Vane J R
The use of isolated organs for detecting active substances in the circulating blood. 1964.
British journal of pharmacology 1997;120(4 Suppl):250-63; discussion 248-9.
-
1997: Vane J R
A sensitive method for the assay of 5-hydroxytryptamine. 1957.
British journal of pharmacology 1997;120(4 Suppl):142-7; discussion 140-1.
-
1997: Vane J R; Meade T W
Second European Stroke Prevention Study (ESPS 2): clinical and pharmacological implications.
Journal of the neurological sciences 1997;145(2):123-5.
-
1997: Thiemermann C; Bowes J; Myint F P; Vane J R
Inhibition of the activity of poly(ADP ribose) synthetase reduces ischemia-reperfusion injury in the heart and skeletal muscle.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(2):679-83.
-
1997: Vane J R; Botting R M
Mechanism of action of anti-inflammatory drugs.
Advances in experimental medicine and biology 1997;433():131-8.
-
1996: Benjamin N; Vane J
Nitric oxide and hypertension.
Circulation 1996;94(6):1197-8.
-
1996: Wood P J; Sansom J M; Stratford I J; Adams G E; Szabo C; Thiemermann C; Vane J R
Changes in energy metabolism and X-ray sensitivity in murine tumours by the nitric oxide donor SIN-1.
The British journal of cancer. Supplement 1996;27():S177-80.
-
1996: Ruetten H; Thiemermann C; Vane J R
Effects of the endothelin receptor antagonist, SB 209670, on circulatory failure and organ injury in endotoxic shock in the anaesthetized rat.
British journal of pharmacology 1996;118(1):198-204.
-
1996: Vane J R
Introduction: mechanism of action of NSAIDs.
British journal of rheumatology 1996;35 Suppl 1():1-3.
-
1996: Vane J R; Botting R M
Mechanism of action of anti-inflammatory drugs.
Scandinavian journal of rheumatology. Supplement 1996;102():9-21.
-
1995: Hohlfeld T; Klemm P; Thiemermann C; Warner T D; Schrör K; Vane J R
The contribution of tumour necrosis factor-alpha and endothelin-1 to the increase of coronary resistance in hearts from rats treated with endotoxin.
British journal of pharmacology 1995;116(8):3309-15.
-
1995: De Kimpe S J; Thiemermann C; Vane J R
Role for intracellular platelet-activating factor in the circulatory failure in a model of gram-positive shock.
British journal of pharmacology 1995;116(8):3191-8.
-
1995: Thiemermann C; Ruetten H; Wu C C; Vane J R
The multiple organ dysfunction syndrome caused by endotoxin in the rat: attenuation of liver dysfunction by inhibitors of nitric oxide synthase.
British journal of pharmacology 1995;116(7):2845-51.
-
1995: Allcock G H; Warner T D; Vane J R
Roles of endothelin receptors in the regional and systemic vascular responses to ET-1 in the anaesthetized ganglion-blocked rat: use of selective antagonists.
British journal of pharmacology 1995;116(5):2482-6.
-
1995: Hide E J; Ney P; Piper J; Thiemermann C; Vane J R
Reduction by prostaglandin E1 or prostaglandin E0 of myocardial infarct size in the rabbit by activation of ATP-sensitive potassium channels.
British journal of pharmacology 1995;116(5):2435-40.
-
1995: Hattori Y; Szabó C; Gross S; Thiemermann C; Vane J R
Lipid A and the lipid A analogue anti-tumour compound ONO-4007 induce nitric oxide synthase in vitro and in vivo.
European journal of pharmacology 1995;291(2):83-90.
-
1995: Vane J R
NSAIDs, Cox-2 inhibitors, and the gut.
Lancet 1995;346(8982):1105-6.
-
1995: Allcock G H; Battistini B; Fournier A; Warner T D; Vane J R
Characterization of endothelin receptors mediating mechanical responses to the endothelins in the isolated stomach strip of the rat.
The Journal of pharmacology and experimental therapeutics 1995;275(1):120-6.
-
1995: De Kimpe S J; Kengatharan M; Thiemermann C; Vane J R
The cell wall components peptidoglycan and lipoteichoic acid from Staphylococcus aureus act in synergy to cause shock and multiple organ failure.
Proceedings of the National Academy of Sciences of the United States of America 1995;92(22):10359-63.
-
1995: Vane J
Trumping the ACE.
Lancet 1995;346(8979):916.
-
1995: Harrison V J; Barnes K; Turner A J; Wood E; Corder R; Vane J R
Identification of endothelin 1 and big endothelin 1 in secretory vesicles isolated from bovine aortic endothelial cells.
Proceedings of the National Academy of Sciences of the United States of America 1995;92(14):6344-8.
-
1995: Akarasereenont P; Bakhle Y S; Thiemermann C; Vane J R
Cytokine-mediated induction of cyclo-oxygenase-2 by activation of tyrosine kinase in bovine endothelial cells stimulated by bacterial lipopolysaccharide.
British journal of pharmacology 1995;115(3):401-8.
-
1995: Battistini B; Woods M; O'Donnell L J; Warner T D; Corder R; Fournier A; Farthing M J; Vane J R
Contractile activity of endothelin precursors in the isolated gallbladder of the guinea-pig: presence of an endothelin-converting enzyme.
British journal of pharmacology 1995;114(7):1383-90.
-
1995: Klemm P; Warner T D; Willis D; Moore A R; Vane J R
Coronary vasoconstriction in vitro in the hearts of polyarthritic rats: effectiveness of in vivo treatment with the endothelin receptor antagonist SB 209670.
British journal of pharmacology 1995;114(7):1327-8.
-
1995: Swierkosz T A; Mitchell J A; Warner T D; Botting R M; Vane J R
Co-induction of nitric oxide synthase and cyclo-oxygenase: interactions between nitric oxide and prostanoids.
British journal of pharmacology 1995;114(7):1335-42.
-
1995: Wu C C; Chen S J; Szabó C; Thiemermann C; Vane J R
Aminoguanidine attenuates the delayed circulatory failure and improves survival in rodent models of endotoxic shock.
British journal of pharmacology 1995;114(8):1666-72.
-
1995: Wu C C; Croxtall J D; Perretti M; Bryant C E; Thiemermann C; Flower R J; Vane J R
Lipocortin 1 mediates the inhibition by dexamethasone of the induction by endotoxin of nitric oxide synthase in the rat.
Proceedings of the National Academy of Sciences of the United States of America 1995;92(8):3473-7.
-
1995: Klemm P; Warner T D; Hohlfeld T; Corder R; Vane J R
Endothelin 1 mediates ex vivo coronary vasoconstriction caused by exogenous and endogenous cytokines.
Proceedings of the National Academy of Sciences of the United States of America 1995;92(7):2691-5.
-
1995: De Kimpe S J; Hunter M L; Bryant C E; Thiemermann C; Vane J R
Delayed circulatory failure due to the induction of nitric oxide synthase by lipoteichoic acid from Staphylococcus aureus in anaesthetized rats.
British journal of pharmacology 1995;114(6):1317-23.
-
1995: Wu C C; Thiemermann C; Vane J R
Glibenclamide-induced inhibition of the expression of inducible nitric oxide synthase in cultured macrophages and in the anaesthetized rat.
British journal of pharmacology 1995;114(6):1273-81.
-
1995: Battistini B; Brown M; Vane J R
Selective proteolitic activation and degradation of ETs and big ETs in parenchymal strips of the guinea-pig lung.
Biochemical and biophysical research communications 1995;207(2):675-81.
-
1995: Corder R; Vane J R
Radioimmunoassay evidence that the pressor effect of big endothelin-1 is due to local conversion to endothelin-1.
Biochemical pharmacology 1995;49(3):375-80.
-
1995: Vane J R; Botting R M
Pharmacodynamic profile of prostacyclin.
The American journal of cardiology 1995;75(3):3A-10A.
-
1995: Vane J R; Botting R M
New insights into the mode of action of anti-inflammatory drugs.
Inflammation research : official journal of the European Histamine Research Society ... [et al.] 1995;44(1):1-10.
-
1995: Akarasereenont P; Mitchell J A; Bakhle Y S; Thiemermann C; Vane J R
Comparison of the induction of cyclooxygenase and nitric oxide synthase by endotoxin in endothelial cells and macrophages.
European journal of pharmacology 1995;273(1-2):121-8.
-
1995: Corder R; Carrier M; Khan N; Klemm P; Vane J R
Cytokine regulation of endothelin-1 release from bovine aortic endothelial cells.
Journal of cardiovascular pharmacology 1995;26 Suppl 3():S56-8.
-
1995: Wellings R P; Corder R; Vane J R
Lack of effect of ET antibody or SB 209670 on endotoxin-induced renal failure.
Journal of cardiovascular pharmacology 1995;26 Suppl 3():S476-8.
-
1995: Kengatharan M; Battistini B; Warner T D; Thiemermann C; Vane J R
Endothelin-1 mediates the increase in ex vivo coronary vascular resistance induced by hemorrhagic shock in the anesthetized rat.
Journal of cardiovascular pharmacology 1995;26 Suppl 3():S422-4.
-
1995: Klemm P; Warner T D; Corder R; Vane J R
Endothelin-1 mediates coronary vasoconstriction caused by exogenous and endogenous cytokines.
Journal of cardiovascular pharmacology 1995;26 Suppl 3():S419-21.
-
1995: Akarasereenont P; Hide E; Ney P; Thiemermann C; Vane J R
The induction of cyclooxygenase-2 elicited by endotoxin in endothelial cells and macrophages is inhibited by prostaglandin E1 and 13,14-dihydro prostaglandin E1.
Agents and actions. Supplements 1995;45():59-64.
-
1995: Vane J R; Botting R M
A better understanding of anti-inflammatory drugs based on isoforms of cyclooxygenase (COX-1 and COX-2).
Advances in prostaglandin, thromboxane, and leukotriene research 1995;23():41-8.
-
1994: Akarasereenont P; Mitchell J A; Appleton I; Thiemermann C; Vane J R
Involvement of tyrosine kinase in the induction of cyclo-oxygenase and nitric oxide synthase by endotoxin in cultured cells.
British journal of pharmacology 1994;113(4):1522-8.
-
1994: Desai K M; Warner T D; Bishop A E; Polak J M; Vane J R
Nitric oxide, and not vasoactive intestinal peptide, as the main neurotransmitter of vagally induced relaxation of the guinea pig stomach.
British journal of pharmacology 1994;113(4):1197-202.
-
1994: Mitchell J A; Belvisi M G; Akarasereenont P; Robbins R A; Kwon O J; Croxtall J; Barnes P J; Vane J R
Induction of cyclo-oxygenase-2 by cytokines in human pulmonary epithelial cells: regulation by dexamethasone.
British journal of pharmacology 1994;113(3):1008-14.
-
1994: Vane J R; Botting R M
Regulatory mechanisms of the vascular endothelium: an update.
Polish journal of pharmacology 1994;46(6):499-21.
-
1994: Swierkosz T A; Mitchell J A; Tomlinson A; Botting R M; Warner T D; Vane J R
Relationship between different isoforms of nitric oxide synthase and cyclooxygenase in various cell types.
Polish journal of pharmacology 1994;46(6):587-92.
-
1994: Szabó C; Southan G J; Thiemermann C; Vane J R
The mechanism of the inhibitory effect of polyamines on the induction of nitric oxide synthase: role of aldehyde metabolites.
British journal of pharmacology 1994;113(3):757-66.
-
1994: Battistini B; O'Donnell L J; Warner T D; Fournier A; Farthing M J; Vane J R
Characterization of endothelin (ET) receptors in the isolated gall bladder of the guinea-pig: evidence for an additional ET receptor subtype.
British journal of pharmacology 1994;112(4):1244-50.
-
1994: McMurdo L; Thiemermann C; Vane J R
The endothelin ETB receptor agonist, IRL 1620, causes vasodilatation and inhibits ex vivo platelet aggregation in the anaesthetised rabbit.
European journal of pharmacology 1994;259(1):51-5.
-
1994: Masaki T; Vane J R; Vanhoutte P M
International Union of Pharmacology nomenclature of endothelin receptors.
Pharmacological reviews 1994;46(2):137-42.
-
1994: Szabó C; Southan G J; Wood E; Thiemermann C; Vane J R
Inhibition by spermine of the induction of nitric oxide synthase in J774.2 macrophages: requirement of a serum factor.
British journal of pharmacology 1994;112(2):355-6.
-
1994: Wood P J; Sansom J M; Stratford I J; Adams G E; Szabo C; Thiemermann C; Vane J R
Modification of metabolism of transplantable and spontaneous murine tumors by the nitric oxide synthase inhibitor, nitro-L-arginine.
International journal of radiation oncology, biology, physics 1994;29(3):443-7.
-
1994: Pistelli A; Mollace V; Nistico G; Salvemini D; Vane J
Nitroblue tetrazolium inhibits oxidation of glyceryl trinitrate to nitric oxide in bovine aortic smooth muscle cells.
Biochemical pharmacology 1994;47(10):1737-42.
-
1994: McMurdo L; Thiemermann C; Vane J R
The effects of the endothelin ETA receptor antagonist, FR 139317, on infarct size in a rabbit model of acute myocardial ischaemia and reperfusion.
British journal of pharmacology 1994;112(1):75-80.
-
1994: Warner T D; Allcock G H; Vane J R
Reversal of established responses to endothelin-1 in vivo and in vitro by the endothelin receptor antagonists, BQ-123 and PD 145065.
British journal of pharmacology 1994;112(1):207-13.
-
1994: Wu C C; Szabó C; Chen S J; Thiemermann C; Vane J R
Activation of soluble guanylyl cyclase by a factor other than nitric oxide or carbon monoxide contributes to the vascular hyporeactivity to vasoconstrictor agents in the aorta of rats treated with endotoxin.
Biochemical and biophysical research communications 1994;201(1):436-42.
-
1994: Korbut R; Warner T D; Gryglewski R J; Vane J R
The effect of nitric oxide synthase inhibition on the plasma fibrinolytic system in septic shock in rats.
British journal of pharmacology 1994;112(1):289-91.
-
1994: Macarthur H; Warner T D; Wood E G; Corder R; Vane J R
Endothelin-1 release from endothelial cells in culture is elevated both acutely and chronically by short periods of mechanical stretch.
Biochemical and biophysical research communications 1994;200(1):395-400.
-
1994: Wellings R P; Corder R; Doherty A M; Vane J R
Antagonism of renal and systemic responses to endothelin-1 infusion with PD 145065.
European journal of pharmacology 1994;256(2):201-4.
-
1994: Battistini B; Warner T D; Fournier A; Vane J R
Characterization of ETB receptors mediating contractions induced by endothelin-1 or IRL 1620 in guinea-pig isolated airways: effects of BQ-123, FR139317 or PD 145065.
British journal of pharmacology 1994;111(4):1009-16.
-
1994: Vane J R; Mitchell J A; Appleton I; Tomlinson A; Bishop-Bailey D; Croxtall J; Willoughby D A
Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation.
Proceedings of the National Academy of Sciences of the United States of America 1994;91(6):2046-50.
-
1994: Battistini B; Warner T D; Fournier A; Vane J R
Comparison of PD 145065 and Ro 46-2005 as antagonists of contractions of guinea-pig airways induced by endothelin-1 or IRL 1620.
European journal of pharmacology 1994;252(3):341-5.
-
1994: Vane J R; Botting R M
Control of the circulation by vasoactive mediators from endothelial cells.
Journal of lipid mediators and cell signalling 1994;9(1):1-8.
-
1994: Wellings R P; Corder R; Warner T D; Cristol J P; Thiemermann C; Vane J R
Evidence from receptor antagonists of an important role for ETB receptor-mediated vasoconstrictor effects of endothelin-1 in the rat kidney.
British journal of pharmacology 1994;111(2):515-20.
-
1994: Vane J R
The Croonian Lecture, 1993. The endothelium: maestro of the blood circulation.
Philosophical transactions of the Royal Society of London. Series B, Biological sciences 1994;343(1304):225-46.
-
1994: Vane J
Towards a better aspirin.
Nature 1994;367(6460):215-6.
-
1994: Desai K M; Warner T D; Vane J R
5-HT3 receptors do not mediate vagally-induced relaxation or contraction of the isolated stomach of the guinea-pig.
British journal of pharmacology 1994;111(1):346-50.
-
1994: Szabó C; Thiemermann C; Wu C C; Perretti M; Vane J R
Attenuation of the induction of nitric oxide synthase by endogenous glucocorticoids accounts for endotoxin tolerance in vivo.
Proceedings of the National Academy of Sciences of the United States of America 1994;91(1):271-5.
-
1994: Vane J R; Botting R M
Mediators from the endothelial cell and their participation in inflammation.
International journal of tissue reactions 1994;16(1):19-49.
-
1993: Mitchell J A; Akarasereenont P; Thiemermann C; Flower R J; Vane J R
Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase.
Proceedings of the National Academy of Sciences of the United States of America 1993;90(24):11693-7.
-
1993: Warner T D; Battistini B; Allcock G H; Vane J R
Endothelin ETA and ETB receptors mediate vasoconstriction and prostanoid release in the isolated kidney of the rat.
European journal of pharmacology 1993;250(3):447-53.
-
1993: Szabó C; Wu C C; Mitchell J A; Gross S S; Thiemermann C; Vane J R
Platelet-activating factor contributes to the induction of nitric oxide synthase by bacterial lipopolysaccharide.
Circulation research 1993;73(6):991-9.
-
1993: Khatsenko O G; Gross S S; Rifkind A B; Vane J R
Nitric oxide is a mediator of the decrease in cytochrome P450-dependent metabolism caused by immunostimulants.
Proceedings of the National Academy of Sciences of the United States of America 1993;90(23):11147-51.
-
1993: Szabó C; Wu C C; Gross S S; Thiemermann C; Vane J R
Interleukin-1 contributes to the induction of nitric oxide synthase by endotoxin in vivo.
European journal of pharmacology 1993;250(1):157-60.
-
1993: Warner T D; Allcock G H; Mickley E J; Vane J R
Characterization of endothelin receptors mediating the effects of the endothelin/sarafotoxin peptides on autonomic neurotransmission in the rat vas deferens and guinea-pig ileum.
British journal of pharmacology 1993;110(2):783-9.
-
1993: Warner T D; Allcock G H; Corder R; Vane J R
Use of the endothelin antagonists BQ-123 and PD 142893 to reveal three endothelin receptors mediating smooth muscle contraction and the release of EDRF.
British journal of pharmacology 1993;110(2):777-82.
-
1993: Szabó C; Thiemermann C; Vane J R
Dihydropyridine antagonists and agonists of calcium channels inhibit the induction of nitric oxide synthase by endotoxin in cultured macrophages.
Biochemical and biophysical research communications 1993;196(2):825-30.
-
1993: Lidbury P S; Cirillo R; Vane J R
Dissociation of the anti-ischaemic effects of cloricromene from its anti-platelet activity.
British journal of pharmacology 1993;110(1):275-80.
-
1993: Szabó C; Thiemermann C; Vane J R
Inhibition of the production of nitric oxide and vasodilator prostaglandins attenuates the cardiovascular response to bacterial endotoxin in adrenalectomized rats.
Proceedings. Biological sciences / The Royal Society 1993;253(1338):233-8.
-
1993: Thiemermann C; Wu C C; Szabó C; Perretti M; Vane J R
Role of tumour necrosis factor in the induction of nitric oxide synthase in a rat model of endotoxin shock.
British journal of pharmacology 1993;110(1):177-82.
-
1993: McMurdo L; Lidbury P S; Thiemermann C; Vane J R
Mediation of endothelin-1-induced inhibition of platelet aggregation via the ETB receptor.
British journal of pharmacology 1993;109(2):530-4.
-
1993: Szabó C; Mitchell J A; Gross S S; Thiemermann C; Vane J R
Nifedipine inhibits the induction of nitric oxide synthase by bacterial lipopolysaccharide.
The Journal of pharmacology and experimental therapeutics 1993;265(2):674-80.
-
1993: Mitchell J A; Kohlhaas K L; Sorrentino R; Warner T D; Murad F; Vane J R
Induction by endotoxin of nitric oxide synthase in the rat mesentery: lack of effect on action of vasoconstrictors.
British journal of pharmacology 1993;109(1):265-70.
-
1993: Cristol J P; Thiemermann C; Mitchell J A; Walder C; Vane J R
Support of renal blood flow after ischaemic-reperfusion injury by endogenous formation of nitric oxide and of cyclo-oxygenase vasodilator metabolites.
British journal of pharmacology 1993;109(1):188-94.
-
1993: Wood P J; Stratford I J; Adams G E; Szabo C; Thiemermann C; Vane J R
Modification of energy metabolism and radiation response of a murine tumour by changes in nitric oxide availability.
Biochemical and biophysical research communications 1993;192(2):505-10.
-
1993: Warner T D; Vane J R
Pharmacology. ET touches down in Houston.
Nature 1993;362(6420):497-8.
-
1993: Cristol J P; Warner T D; Thiemermann C; Vane J R
Mediation via different receptors of the vasoconstrictor effects of endothelins and sarafotoxins in the systemic circulation and renal vasculature of the anaesthetized rat.
British journal of pharmacology 1993;108(3):776-9.
-
1993: Vane J R; Botting R M
Formation by the endothelium of prostacyclin, nitric oxide and endothelin.
Journal of lipid mediators 1993;6(1-3):395-404.
-
1993: Szabó C; Mitchell J A; Thiemermann C; Vane J R
Nitric oxide-mediated hyporeactivity to noradrenaline precedes the induction of nitric oxide synthase in endotoxin shock.
British journal of pharmacology 1993;108(3):786-92.
-
1993: McMurdo L; Corder R; Thiemermann C; Vane J R
Incomplete inhibition of the pressor effects of endothelin-1 and related peptides in the anaesthetized rat with BQ-123 provides evidence for more than one vasoconstrictor receptor.
British journal of pharmacology 1993;108(2):557-61.
-
1993: Macarthur H; Hecker M; Busse R; Vane J R
Selective inhibition of agonist-induced but not shear stress-dependent release of endothelial autacoids by thapsigargin.
British journal of pharmacology 1993;108(1):100-5.
-
1993: Salvemini D; Pistelli A; Vane J
Conversion of glyceryl trinitrate to nitric oxide in tolerant and non-tolerant smooth muscle and endothelial cells.
British journal of pharmacology 1993;108(1):162-9.
-
1993: Thiemermann C; Szabó C; Mitchell J A; Vane J R
Vascular hyporeactivity to vasoconstrictor agents and hemodynamic decompensation in hemorrhagic shock is mediated by nitric oxide.
Proceedings of the National Academy of Sciences of the United States of America 1993;90(1):267-71.
-
1993: Vane J
Control of the circulation by endothelial mediators. Inaugural G.B. West Memorial Lecture.
International archives of allergy and immunology 1993;101(4):333-45.
-
1993: Corder R; Harrison V J; Khan N; Anggård E E; Vane J R
Effects of phosphoramidon in endothelial cell cultures on the endogenous synthesis of endothelin-1 and on conversion of exogenous big endothelin-1 to endothelin-1.
Journal of cardiovascular pharmacology 1993;22 Suppl 8():S73-6.
-
1993: Kaw S; Warner T D; Vane J R
The metabolism of endothelin-1 and big endothelin-1 by the isolated perfused kidney of the rabbit.
Journal of cardiovascular pharmacology 1993;22 Suppl 8():S65-8.
-
1993: Harrison V J; Corder R; Anggård E E; Vane J R
Evidence for vesicles that transport endothelin-1 in bovine aortic endothelial cells.
Journal of cardiovascular pharmacology 1993;22 Suppl 8():S57-60.
-
1993: Corder R; Khan N; Anggård E E; Vane J R
Calcium ionophores inhibit the release of endothelin-1 from endothelial cells.
Journal of cardiovascular pharmacology 1993;22 Suppl 8():S42-5.
-
1993: McMurdo L; Lidbury P S; Corder R; Thiemermann C; Vane J R
Heterogeneous receptors mediate endothelin-1-induced changes in blood pressure, hematocrit, and platelet aggregation.
Journal of cardiovascular pharmacology 1993;22 Suppl 8():S185-8.
-
1993: Warner T D; Allcock G H; Mickley E J; Corder R; Vane J R
Comparative studies with the endothelin receptor antagonists BQ-123 and PD 142893 indicate at least three endothelin receptors.
Journal of cardiovascular pharmacology 1993;22 Suppl 8():S117-20.
-
1993: Wellings R P; Warner T D; Thiemermann C; Cristol J P; Corder R; Vane J R
Vasoconstriction in the rat kidney induced by endothelin-1 is blocked by PD 145065.
Journal of cardiovascular pharmacology 1993;22 Suppl 8():S103-6.
-
1993: Gross S S; Levi R; Madera A; Park K H; Vane J; Hattori Y
Tetrahydrobiopterin synthesis is induced by LPS in vascular smooth muscle and is rate-limiting for nitric oxide production.
Advances in experimental medicine and biology 1993;338():295-300.
-
1992: Zembowicz A; Chlopicki S; Radziszewski W; Vane J R; Gryglewski R J
NG-hydroxy-L-arginine and hydroxyguanidine potentiate the biological activity of endothelium-derived relaxing factor released from the rabbit aorta.
Biochemical and biophysical research communications 1992;189(2):711-6.
-
1992: Zembowicz A; Swierkosz T A; Southan G J; Hecker M; Vane J R
Potentiation of the vasorelaxant activity of nitric oxide by hydroxyguanidine: implications for the nature of endothelium-derived relaxing factor.
British journal of pharmacology 1992;107(4):1001-7.
-
1992: Walder C E; Thiemermann C; Vane J R
NG-hydroxy-L-arginine prevents the haemodynamic effects of nitric oxide synthesis inhibition in the anaesthetized rat.
British journal of pharmacology 1992;107(2):476-80.
-
1992: Sprague R S; Thiemermann C; Vane J R
Endogenous endothelium-derived relaxing factor opposes hypoxic pulmonary vasoconstriction and supports blood flow to hypoxic alveoli in anesthetized rabbits.
Proceedings of the National Academy of Sciences of the United States of America 1992;89(18):8711-5.
-
1992: Vane J R; Botting R M
Secretory functions of the vascular endothelium.
Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 1992;43(3):195-207.
-
1992: Kaw S; Hecker M; Vane J R
The two-step conversion of big endothelin 1 to endothelin 1 and degradation of endothelin 1 by subcellular fractions from human polymorphonuclear leukocytes.
Proceedings of the National Academy of Sciences of the United States of America 1992;89(15):6886-90.
-
1992: Salvemini D; Mollace V; Pistelli A; Anggård E; Vane J
Cultured astrocytoma cells generate a nitric oxide-like factor from endogenous L-arginine and glyceryl trinitrate: effect of E. coli lipopolysaccharide.
British journal of pharmacology 1992;106(4):931-6.
-
1992: Gryglewski R J; Zembowicz A; Salvemini D; Taylor G W; Vane J R
Modulation of the pharmacological actions of nitrovasodilators by methylene blue and pyocyanin.
British journal of pharmacology 1992;106(4):838-45.
-
1992: Salvemini D; Pistelli A; Mollace V; Anggård E; Vane J
The metabolism of glyceryl trinitrate to nitric oxide in the macrophage cell line J774 and its induction by Escherichia coli lipopolysaccharide.
Biochemical pharmacology 1992;44(1):17-24.
-
1992: D'Orleans-Juste P; Mitchell J A; Wood E G; Hecker M; Vane J R
Comparison of the release of vasoactive factors from venous and arterial bovine cultured endothelial cells.
Canadian journal of physiology and pharmacology 1992;70(5):687-94.
-
1992: Hecker M; Siegle I; Macarthur H; Sessa W C; Vane J R
Role of intracellular thiols in release of EDRF from cultured endothelial cells.
The American journal of physiology 1992;262(3 Pt 2):H888-96.
-
1992: Zembowicz A; Vane J R
Induction of nitric oxide synthase activity by toxic shock syndrome toxin 1 in a macrophage-monocyte cell line.
Proceedings of the National Academy of Sciences of the United States of America 1992;89(6):2051-5.
-
1992: Withrington P G; Ansari N; Croxton R; de Nucci G; Vane J R
The actions of endothelins-1 and -3 on the vascular and capsular smooth muscle of the isolated blood perfused spleen of the dog.
British journal of pharmacology 1992;105(2):490-4.
-
1992: Mitchell J A; de Nucci G; Warner T D; Vane J R
Different patterns of release of endothelium-derived relaxing factor and prostacyclin.
British journal of pharmacology 1992;105(2):485-9.
-
1992: Salvemini D; Mollace V; Pistelli A; Anggard E; Vane J
Metabolism of glyceryl trinitrate to nitric oxide by endothelial cells and smooth muscle cells and its induction by Escherichia coli lipopolysaccharide.
Proceedings of the National Academy of Sciences of the United States of America 1992;89(3):982-6.
-
1992: Vane J R; Botting R M
The role of chemical mediators released by the endothelium in the control of the cardiovascular system.
International journal of tissue reactions 1992;14(2):55-64.
-
1992: Zembowicz A; Swierkosz T A; Southan G J; Hecker M; Gryglewski R J; Vane J R
Mechanisms of the endothelium-dependent relaxation induced by NG-hydroxy-L-arginine.
Journal of cardiovascular pharmacology 1992;20 Suppl 12():S57-9.
-
1992: Kaw S; Hecker M; Southan G J; Warner T D; Vane J R
Characterization of serine protease-derived metabolites of big endothelin in the cytosolic fraction from human polymorphonuclear leukocytes.
Journal of cardiovascular pharmacology 1992;20 Suppl 12():S22-4.
-
1992: Hecker M; Walsh D T; Vane J R
Characterization of a microsomal calcium-dependent nitric oxide synthase in activated J774.2 monocyte/macrophages.
Journal of cardiovascular pharmacology 1992;20 Suppl 12():S139-41.
-
1991: Vane J R; Botting R M
Heart disease, aspirin, and fish oil.
Circulation 1991;84(6):2588-90.
-
1991: Mollace V; Salvemini D; Vane J
Studies on the importance of the proposed release of nitric oxide from platelets.
Thrombosis research 1991;64(5):533-42.
-
1991: Hecker M; Walsh D T; Vane J R
On the substrate specificity of nitric oxide synthase.
FEBS letters 1991;294(3):221-4.
-
1991: Desai K M; Zembowicz A; Sessa W C; Vane J R
Nitroxergic nerves mediate vagally induced relaxation in the isolated stomach of the guinea pig.
Proceedings of the National Academy of Sciences of the United States of America 1991;88(24):11490-4.
-
1991: Zembowicz A; Hecker M; Macarthur H; Sessa W C; Vane J R
Nitric oxide and another potent vasodilator are formed from NG-hydroxy-L-arginine by cultured endothelial cells.
Proceedings of the National Academy of Sciences of the United States of America 1991;88(24):11172-6.
-
1991: Mollace V; Salvemini D; Anggard E; Vane J
Nitric oxide from vascular smooth muscle cells: regulation of platelet reactivity and smooth muscle cell guanylate cyclase.
British journal of pharmacology 1991;104(3):633-8.
-
1991: Vane J
[New perspectives in the knowledge of endothelial mediators: their repercussion in clinical medicine. Fernandez-Cruz Lecture]
Revista clínica española 1991;189(6):286-92.
-
1991: Thiemermann C; Mustafa M; Mester P A; Mitchell J A; Hecker M; Vane J R
Inhibition of the release of endothelium-derived relaxing factor in vitro and in vivo by dipeptides containing NG-nitro-L-arginine.
British journal of pharmacology 1991;104(1):31-8.
-
1991: Mollace V; Salvemini D; Sessa W C; Vane J R
Inhibition of human platelet aggregation by endothelium-derived relaxing factor, sodium nitroprusside or iloprost is potentiated by captopril and reduced thiols.
The Journal of pharmacology and experimental therapeutics 1991;258(3):820-3.
-
1991: Vane J; O'Grady J
Clinical pharmacology in the pharmaceutical industry.
British journal of clinical pharmacology 1991;32(2):155-7.
-
1991: Mitchell J A; de Nucci G; Warner T D; Vane J R
Alkaline buffers release EDRF from bovine cultured aortic endothelial cells.
British journal of pharmacology 1991;103(2):1295-302.
-
1991: Salvemini D; Radziszewski W; Mollace V; Moore A; Willoughby D; Vane J
Diphenylene iodonium, an inhibitor of free radical formation, inhibits platelet aggregation.
European journal of pharmacology 1991;199(1):15-8.
-
1991: Masini E; Mannaioni P F; Pistelli A; Salvemini D; Vane J
Impairment of the L-arginine-nitric oxide pathway in mast cells from spontaneously hypertensive rats.
Biochemical and biophysical research communications 1991;177(3):1178-82.
-
1991: Desai K M; Sessa W C; Vane J R
Involvement of nitric oxide in the reflex relaxation of the stomach to accommodate food or fluid.
Nature 1991;351(6326):477-9.
-
1991: Masini E; Salvemini D; Pistelli A; Mannaioni P F; Vane J R
Rat mast cells synthesize a nitric oxide like-factor which modulates the release of histamine.
Agents and actions 1991;33(1-2):61-3.
-
1991: Walder C E; Thiemermann C; Vane J R
The involvement of endothelium-derived relaxing factor in the regulation of renal cortical blood flow in the rat.
British journal of pharmacology 1991;102(4):967-73.
-
1991: MacIntyre I; Zaidi M; Alam A S; Datta H K; Moonga B S; Lidbury P S; Hecker M; Vane J R
Osteoclastic inhibition: an action of nitric oxide not mediated by cyclic GMP.
Proceedings of the National Academy of Sciences of the United States of America 1991;88(7):2936-40.
-
1991: Salvemini D; de Nucci G; Vane J R
Superoxide dismutase cooperates with prostacyclin to inhibit platelet aggregation: a comparative study in washed platelets and platelet rich plasma.
Thrombosis and haemostasis 1991;65(4):421-4.
-
1991: Vane J R; Botting R M
Endothelium-derived vasoactive factors and the control of the circulation.
Seminars in perinatology 1991;15(1):4-10.
-
1991: Thiemermann C; al-Damluji S; Hecker M; Vane J R
FMRF-amide and L-Arg-L-Phe increase blood pressure and heart rate in the anaesthetised rat by central stimulation of the sympathetic nervous system.
Biochemical and biophysical research communications 1991;175(1):318-24.
-
1991: Sessa W C; Kaw S; Hecker M; Vane J R
The biosynthesis of endothelin-1 by human polymorphonuclear leukocytes.
Biochemical and biophysical research communications 1991;174(2):613-8.
-
1991: Vane J R; Botting R M
Endothelium--thromboresistance.
Wiener klinische Wochenschrift 1991;103(14):403-4.
-
1991: Vane J R; Botting R
Mediators from the endothelial cell.
Advances in prostaglandin, thromboxane, and leukotriene research 1991;21B():627-36.
-
1991: Vane J R; Botting R M
The present status of eicosanoids and related substances in the control of the cardiovascular system.
Wiener klinische Wochenschrift 1991;103(18):541-2.
-
1991: Mannaioni P F; Masini E; Pistelli A; Salvemini D; Vane J R
Mast cells as a source of superoxide anions and nitric oxide-like factor: relevance to histamine release.
International journal of tissue reactions 1991;13(6):271-8.
-
1991: Huneidi A H; Thiemermann C; Lidbury P S; D'Orléans-Juste P; Anggård E E; Afshar F; Vane J R
Endothelin-1 and big endothelin cause subarachnoid hemorrhage in the anesthetized rabbit.
Journal of cardiovascular pharmacology 1991;17 Suppl 7():S492-5.
-
1991: Sessa W C; Kaw S; Zembowicz A; Anggård E; Hecker M; Vane J R
Human polymorphonuclear leukocytes generate and degrade endothelin-1 by two distinct neutral proteases.
Journal of cardiovascular pharmacology 1991;17 Suppl 7():S34-8.
-
1991: D'Orléans-Juste P; Lidbury P S; Telemaque S; Warner T D; Vane J R
Human big endothelin releases prostacyclin in vivo and in vitro through a phosphoramidon-sensitive conversion to endothelin-1.
Journal of cardiovascular pharmacology 1991;17 Suppl 7():S251-5.
-
1991: Mannaioni P F; Masini E; Pistelli A; Salvemini D; Vane J R
Rat mast cells inhibit platelet aggregation by releasing a nitric oxide-like factor: influence of histamine release.
Agents and actions. Supplements 1991;33():423-8.
-
1990: Vane J
Endothelins come home to roost.
Nature 1990;348(6303):673.
-
1990: Vane J R; Flower R J; Botting R M
History of aspirin and its mechanism of action.
Stroke; a journal of cerebral circulation 1990;21(12 Suppl):IV12-23.
-
1990: Salvemini D; Radziszewski W; Korbut R; Vane J
The use of oxyhaemoglobin to explore the events underlying inhibition of platelet aggregation induced by NO or NO-donors.
British journal of pharmacology 1990;101(4):991-5.
-
1990: Hecker M; Sessa W C; Harris H J; Anggård E E; Vane J R
The metabolism of L-arginine and its significance for the biosynthesis of endothelium-derived relaxing factor: cultured endothelial cells recycle L-citrulline to L-arginine.
Proceedings of the National Academy of Sciences of the United States of America 1990;87(21):8612-6.
-
1990: Lidbury P S; Korbut R; Vane J R
Sodium nitroprusside modulates the fibrinolytic system in the rabbit.
British journal of pharmacology 1990;101(3):527-30.
-
1990: Sessa W C; Hecker M; Mitchell J A; Vane J R
The metabolism of L-arginine and its significance for the biosynthesis of endothelium-derived relaxing factor: L-glutamine inhibits the generation of L-arginine by cultured endothelial cells.
Proceedings of the National Academy of Sciences of the United States of America 1990;87(21):8607-11.
-
1990: Hecker M; Mitchell J A; Swierkosz T A; Sessa W C; Vane J R
Inhibition by L-glutamine of the release of endothelium-derived relaxing factor from cultured endothelial cells.
British journal of pharmacology 1990;101(2):237-9.
-
1990: Warner T D; D'Orleans-Juste P; Vane J R
Endothelin-1 and U46619 potentiate selectively the venous responses to nerve stimulation within the perfused superior mesenteric vascular bed of the rat.
Biochemical and biophysical research communications 1990;172(2):745-50.
-
1990: Mollace V; Salvemini D; Anggård E; Vane J
Cultured astrocytoma cells inhibit platelet aggregation by releasing a nitric oxide-like factor.
Biochemical and biophysical research communications 1990;172(2):564-9.
-
1990: Swierkosz T A; Mitchell J A; Sessa W C; Hecker M; Vane J R
L-glutamine inhibits the release of endothelium-derived relaxing factor from the rabbit aorta.
Biochemical and biophysical research communications 1990;172(1):143-8.
-
1990: Lidbury P S; Thiemermann C; Korbut R; Vane J R
Endothelins release tissue plasminogen activator and prostanoids.
European journal of pharmacology 1990;186(2-3):205-12.
-
1990: Walder C E; Thiemermann C; Vane J R
Endothelium-derived relaxing factor participates in the increased blood flow in response to pentagastrin in the rat stomach mucosa.
Proceedings. Biological sciences / The Royal Society 1990;241(1302):195-200.
-
1990: Thiemermann C; Vane J
Inhibition of nitric oxide synthesis reduces the hypotension induced by bacterial lipopolysaccharides in the rat in vivo.
European journal of pharmacology 1990;182(3):591-5.
-
1990: Mitchell J A; Hecker M; Anggård E E; Vane J R
Cultured endothelial cells maintain their L-arginine level despite the continuous release of EDRF.
European journal of pharmacology 1990;182(3):573-6.
-
1990: Vane J R; Anggård E E; Botting R M
Regulatory functions of the vascular endothelium.
The New England journal of medicine 1990;323(1):27-36.
-
1990: Salvemini D; Masini E; Anggard E; Mannaioni P F; Vane J
Synthesis of a nitric oxide-like factor from L-arginine by rat serosal mast cells: stimulation of guanylate cyclase and inhibition of platelet aggregation.
Biochemical and biophysical research communications 1990;169(2):596-601.
-
1990: Botting R M; Vane J R
Endothelins: potent releasers of prostacyclin and EDRF.
Polish journal of pharmacology and pharmacy 1990;42(3):203-18.
-
1990: D'Orléans-Juste P; Lidbury P S; Warner T D; Vane J R
Intravascular big endothelin increases circulating levels of endothelin-1 and prostanoids in the rabbit.
Biochemical pharmacology 1990;39(9):R21-2.
-
1990: Salvemini D; Korbut R; Anggård E; Vane J
Immediate release of a nitric oxide-like factor from bovine aortic endothelial cells by Escherichia coli lipopolysaccharide.
Proceedings of the National Academy of Sciences of the United States of America 1990;87(7):2593-7.
-
1990: Hecker M; Mitchell J A; Harris H J; Katsura M; Thiemermann C; Vane J R
Endothelial cells metabolize NG-monomethyl-L-arginine to L-citrulline and subsequently to L-arginine.
Biochemical and biophysical research communications 1990;167(3):1037-43.
-
1990: Spurej E; Sneddon J M; Vane J R
The influence of pH on aggregation of human washed platelets induced by thrombin or collagen.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 1990;1(1):47-53.
-
1990: Korbut R; Lidbury P S; Vane J R
Prolongation of fibrinolytic activity of tissue plasminogen activator by nitrovasodilators.
Lancet 1990;335(8690):669.
-
1990: Sinzinger H; Fitscha P; O'Grady J; Rauscha F; Rogatti W; Vane J R
Synergistic effect of prostaglandin E1 and isosorbide dinitrate in peripheral vascular disease.
Lancet 1990;335(8690):627-8.
-
1990: Mitchell J A; Hecker M; Vane J R
The generation of L-arginine in endothelial cells is linked to the release of endothelium-derived relaxing factor.
European journal of pharmacology 1990;176(2):253-4.
-
1990: Thiemermann C; May G R; Page C P; Vane J R
Endothelin-1 inhibits platelet aggregation in vivo: a study with 111indium-labelled platelets.
British journal of pharmacology 1990;99(2):303-8.
-
1990: Thomas G R; Walder C E; Thiemermann C; Vane J R
Regional vascular resistance and haemodynamics in the spontaneously hypertensive rat: the effects of bradykinin.
Journal of cardiovascular pharmacology 1990;15(2):211-7.
-
1990: Sinzinger H; Fitscha P; Rauscha F; O'Grady J; Rogatti W; Vane J R
Effect of prostaglandin E1 and (the NO-donor) isosorbidedinitrate on thromboresistance in human in-vivo.
Progress in clinical and biological research 1990;355():55-62.
-
1990: Anggård E E; Botting R M; Vane J R
Endothelins.
Blood vessels 1990;27(2-5):269-81.
-
1990: Vane J R; Botting R M
The mode of action of anti-inflammatory drugs.
Postgraduate medical journal 1990;66 Suppl 4():S2-17.
-
1989: Fuxe K; Anggård E; Lundgren K; Cintra A; Agnati L F; Galton S; Vane J
Localization of [125I]endothelin-1 and [125I]endothelin-3 binding sites in the rat brain.
Acta physiologica Scandinavica 1989;137(4):563-4.
-
1989: Lidbury P S; Antunes E; de Nucci G; Vane J R
Interactions of iloprost and sodium nitroprusside on vascular smooth muscle and platelet aggregation.
British journal of pharmacology 1989;98(4):1275-80.
-
1989: Salvemini D; Korbut R; Anggård E; Vane J R
Lipopolysaccharide increases release of a nitric oxide-like factor from endothelial cells.
European journal of pharmacology 1989;171(1):135-6.
-
1989: Botting R; Vane J R
Vasoactive mediators derived from the endothelium.
Archives des maladies du coeur et des vaisseaux 1989;82 Spec No 4():11-4.
-
1989: Kondo K; Mitchell J A; de Nucci G; Vane J R
Simultaneous measurement of endothelium-derived relaxing factor by bioassay and guanylate cyclase stimulation.
British journal of pharmacology 1989;98(2):630-6.
-
1989: Korbut R; Lidbury P; Thomas G R; Vane J R
Fibrinolytic activity of endothelin-3.
Thrombosis research 1989;55(6):797-9.
-
1989: Salvemini D; de Nucci G; Sneddon J M; Vane J R
Superoxide anions enhance platelet adhesion and aggregation.
British journal of pharmacology 1989;97(4):1145-50.
-
1989: Salvemini D; de Nucci G; Gryglewski R J; Vane J R
Human neutrophils and mononuclear cells inhibit platelet aggregation by releasing a nitric oxide-like factor.
Proceedings of the National Academy of Sciences of the United States of America 1989;86(16):6328-32.
-
1989: Lidbury P S; Thiemermann C; Thomas G R; Vane J R
Endothelin-3: selectivity as an anti-aggregatory peptide in vivo.
European journal of pharmacology 1989;166(2):335-8.
-
1989: Warner T D; de Nucci G; Vane J R
Comparison of the survival of endothelium-derived relaxing factor and nitric oxide within the isolated perfused mesenteric arterial bed of the rat.
British journal of pharmacology 1989;97(3):777-82.
-
1989: Thiemermann C; Thomas G R; Vane J R
Defibrotide reduces infarct size in a rabbit model of experimental myocardial ischaemia and reperfusion.
British journal of pharmacology 1989;97(2):401-8.
-
1989: Barrett M L; Willis A L; Vane J R
Inhibition of platelet-derived mitogen release by nitric oxide (EDRF).
Agents and actions 1989;27(3-4):488-91.
-
1989: D'Orleans-Juste P; De Nucci G; Vane J R
Endothelin-1 contracts isolated vessels independently of dihydropyridine-sensitive Ca2+ channel activation.
European journal of pharmacology 1989;165(2-3):289-95.
-
1989: D'Orléans-Juste P; de Nucci G; Vane J R
Kinins act on B1 or B2 receptors to release conjointly endothelium-derived relaxing factor and prostacyclin from bovine aortic endothelial cells.
British journal of pharmacology 1989;96(4):920-6.
-
1989: Botting R; Vane J R
Mediators and the anti-thrombotic properties of the vascular endothelium.
Annals of medicine 1989;21(1):31-8.
-
1989: Vane J R; Guarnaccia V J
Personality theory and personality assessment measures: how helpful to the clinician?
Journal of clinical psychology 1989;45(1):5-19.
-
1989: Warner T D; de Nucci G; Vane J R
Rat endothelin is a vasodilator in the isolated perfused mesentery of the rat.
European journal of pharmacology 1989;159(3):325-6.
-
1989: Thiemermann C; Thomas G R; Vane J R
Effects of defibrotide on infarct size and regional myocardial blood flow on the ischaemic reperfused rabbit heart.
Progress in clinical and biological research 1989;301():131-5.
-
1989: Botting R; Vane J R
Chemical mediators and the anti-thrombotic properties of endothelial cells.
Advances in prostaglandin, thromboxane, and leukotriene research 1989;19():11-20.
-
1989: Botting R; Vane J R
The receipt and dispatch of chemical messengers by endothelial cells.
Progress in clinical and biological research 1989;301():1-11.
-
1989: Walder C E; Thomas G R; Thiemermann C; Vane J R
The hemodynamic effects of endothelin-1 in the pithed rat.
Journal of cardiovascular pharmacology 1989;13 Suppl 5():S93-7; discussion S102.
-
1989: Rae G A; Trybulec M; de Nucci G; Vane J R
Endothelin-1 releases eicosanoids from rabbit isolated perfused kidney and spleen.
Journal of cardiovascular pharmacology 1989;13 Suppl 5():S89-92; discussion S102.
-
1989: Warner T D; Mitchell J A; de Nucci G; Vane J R
Endothelin-1 and endothelin-3 release EDRF from isolated perfused arterial vessels of the rat and rabbit.
Journal of cardiovascular pharmacology 1989;13 Suppl 5():S85-8; discussion S102.
-
1989: Anggård E; Galton S; Rae G; Thomas R; McLoughlin L; de Nucci G; Vane J R
The fate of radioiodinated endothelin-1 and endothelin-3 in the rat.
Journal of cardiovascular pharmacology 1989;13 Suppl 5():S46-9; discussion S74.
-
1989: Withrington P G; de Nucci G; Vane J R
Endothelin-1 causes vasoconstriction and vasodilation in the blood perfused liver of the dog.
Journal of cardiovascular pharmacology 1989;13 Suppl 5():S209-10.
-
1989: D'Orleans-Juste P; Finet M; de Nucci G; Vane J R
Pharmacology of endothelin-1 in isolated vessels: effect of nicardipine, methylene blue, hemoglobin, and gossypol.
Journal of cardiovascular pharmacology 1989;13 Suppl 5():S19-22; discussion S45.
-
1989: Thiemermann C; Lidbury P S; Thomas G R; Vane J R
Endothelin-1 releases prostacyclin and inhibits ex vivo platelet aggregation in the anesthetized rabbit.
Journal of cardiovascular pharmacology 1989;13 Suppl 5():S138-41; discussion S142.
-
1988: Thiemermann C; Lidbury P; Thomas R; Vane J
Endothelin inhibits ex vivo platelet aggregation in the rabbit.
European journal of pharmacology 1988;158(1-2):181-2.
-
1988: Gryglewski R J; Botting R M; Vane J R
Mediators produced by the endothelial cell.
Hypertension 1988;12(6):530-48.
-
1988: de Nucci G; Thomas R; D'Orleans-Juste P; Antunes E; Walder C; Warner T D; Vane J R
Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor.
Proceedings of the National Academy of Sciences of the United States of America 1988;85(24):9797-800.
-
1988: Thomas G R; Thiemermann C; Walder C; Vane J R
The effects of endothelium-dependent vasodilators on cardiac output and their distribution in the anaesthetized rat: a comparison with sodium nitroprusside.
British journal of pharmacology 1988;95(3):986-92.
-
1988: de Nucci G; Warner T; Vane J R
Effect of captopril on the bradykinin-induced release of prostacyclin from guinea-pig lungs and bovine aortic endothelial cells.
British journal of pharmacology 1988;95(3):783-8.
-
1988: Sneddon J M; Vane J R
Endothelium-derived relaxing factor reduces platelet adhesion to bovine endothelial cells.
Proceedings of the National Academy of Sciences of the United States of America 1988;85(8):2800-4.
-
1988: de Nucci G; Gryglewski R J; Warner T D; Vane J R
Receptor-mediated release of endothelium-derived relaxing factor and prostacyclin from bovine aortic endothelial cells is coupled.
Proceedings of the National Academy of Sciences of the United States of America 1988;85(7):2334-8.
-
1988: Vane J R
Prostaglandin research.
Eicosanoids 1988;1(1):1-2.
-
1987: Vane J; Botting R
Inflammation and the mechanism of action of anti-inflammatory drugs.
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 1987;1(2):89-96.
-
1987: Higgs G A; Salmon J A; Henderson B; Vane J R
Pharmacokinetics of aspirin and salicylate in relation to inhibition of arachidonate cyclooxygenase and antiinflammatory activity.
Proceedings of the National Academy of Sciences of the United States of America 1987;84(5):1417-20.
-
1987: Vane J
The evolution of non-steroidal anti-inflammatory drugs and their mechanisms of action.
Drugs 1987;33 Suppl 1():18-27.
-
1987: Vane J R
Antiinflammatory drugs and the many mediators of inflammation.
International journal of tissue reactions 1987;9(1):1-14.
-
1986: Higgs E A; Moncada S; Vane J R
Prostaglandins and thromboxanes from fatty acids.
Progress in lipid research 1986;25(1-4):5-11.
-
1985: Vane J
Pathways to new drugs.
Scandinavian journal of infectious diseases. Supplementum 1985;47():5-8.
-
1985: Vane J R
The road to prostacyclin.
Advances in prostaglandin, thromboxane, and leukotriene research 1985;15():11-9.
-
1984: Vane J; Cuatrecasas P
Genetic engineering and pharmaceuticals.
Nature 1984;312(5992):303-5.
-
1984: Oliva D; Noè A; Nicosia S; Bernini F; Fumagalli R; Whittle B J; Moncada S; Vane J R
Prostacyclin-sensitive adenylate cyclase in cultured myocytes: differences between rabbit aorta and mesenteric artery.
European journal of pharmacology 1984;105(3-4):207-13.
-
1984: Higgs G A; Mugridge K G; Moncada S; Vane J R
Inhibition of tissue damage by the arachidonate lipoxygenase inhibitor BW755C.
Proceedings of the National Academy of Sciences of the United States of America 1984;81(9):2890-2.
-
1984: Salmon J A; Higgs G A; Tilling L; Moncada S; Vane J R
Mode of action of benoxaprofen.
Lancet 1984;1(8381):848.
-
1984: Lombroso M; Nicosia S; Paoletti R; Whittle B J; Moncada S; Vane J R
The use of stable prostaglandins to investigate prostacyclin (PGI2)-binding sites and PGI2-sensitive adenylate cyclase in human platelet membranes.
Prostaglandins 1984;27(2):321-33.
-
1984: Whittle B J; Vane J R
A biochemical basis for the gastrointestinal toxicity of non-steroid antirheumatoid drugs.
Archives of toxicology. Supplement. = Archiv für Toxikologie. Supplement 1984;7():315-22.
-
1984: Higgs G A; Moncada S; Vane J R
Eicosanoids in inflammation.
Annals of clinical research 1984;16(5-6):287-99.
-
1984: Moncada S; Vane J R
Prostacyclin and its clinical applications.
Annals of clinical research 1984;16(5-6):241-52.
-
1983: Vane J R
Nobel lecture. Adventures and excursions in bioassay--the stepping stones to prostacyclin.
Postgraduate medical journal 1983;59(698):743-58.
-
1983: Vane J R
Nobel lecture, 8th December 1982. Adventures and excursions in bioassay: the stepping stones to prostacyclin.
British journal of pharmacology 1983;79(4):821-38.
-
1983: Vane J R
Adventures and excursions in bioassay: the stepping stones to prostacyclin. Nobel Lecture, 8 December 1982.
Bioscience reports 1983;3(8):683-711.
-
1983: Higgs G A; Vane J R
Inhibition of cyclo-oxygenase and lipoxygenase.
British medical bulletin 1983;39(3):265-70.
-
1983: Bunting S; Moncada S; Vane J R
The prostacyclin--thromboxane A2 balance: pathophysiological and therapeutic implications.
British medical bulletin 1983;39(3):271-6.
-
1983: Vane J R
Prostaglandins and the cardiovascular system.
British heart journal 1983;49(5):405-9.
-
1983: Vane J R
Prostacyclin.
Journal of the Royal Society of Medicine 1983;76(4):245-9.
-
1983: Salmon J A; Higgs G A; Vane J R; Bitensky L; Chayen J; Henderson B; Cashman B
Synthesis of arachidonate cyclo-oxygenase products by rheumatoid and nonrheumatoid synovial lining in nonproliferative organ culture.
Annals of the rheumatic diseases 1983;42(1):36-9.
-
1983: Whittle B J; Moncada S; Mullane K; Vane J R
Platelet and cardiovascular activity of the hydantoin BW245C, a potent prostaglandin analogue.
Prostaglandins 1983;25(2):205-23.
-
1983: Vane J R
Clinical potential of prostacyclin.
Advances in prostaglandin, thromboxane, and leukotriene research 1983;11():449-56.
-
1982: Vane J R
Prostacyclin: a hormone with a therapeutic potential. The Sir Henry Dale Lecture for 1981.
The Journal of endocrinology 1982;95(2):3P-43P.
-
1982: Vane J R
Prostacyclin: a prostaglandin with therapeutic potential.
Archivos de farmacología y toxicología 1982;8(2):51-76.
-
1982: Fabiani J N; Bunting S; Terrier E; O'Grady J; Fontaine B; Prigent C; Carpentier A; Vane J; Dubost C
[Clinical study of prostacyclin in extracorporeal circulation. Effects on hemodynamics and coagulation]
Archives des maladies du coeur et des vaisseaux 1982;75(3):241-8.
-
1982: Vane J R
J.H. Burn: an appreciation.
British journal of pharmacology 1982;75(1):3-7.
-
1982: Moncada S; Vane J R
Drugs that modulate prostaglandins, prostacyclin, and thromboxane A2.
Drug therapeutics 1982;():37-65.
-
1982: Vane J R; Bunting S; Moncada S
Prostacyclin in physiology and pathophysiology.
International review of experimental pathology 1982;23():161-207.
-
1982: Dusting G J; Moncada S; Vane J R
Prostacyclin: its biosynthesis, actions, and clinical potential.
Advances in prostaglandin, thromboxane, and leukotriene research 1982;10():59-106.
-
1982: Narumiya S; Salmon J A; Flower R J; Vane J R
Purification and properties of arachidonate-15-lipoxygenase from rabbit peritoneal polymorphonuclear leukocytes.
Advances in prostaglandin, thromboxane, and leukotriene research 1982;9():77-82.
-
1981: Moncada S; Vane J R
Prostacyclin: homeostatic regulator or biological curiosity?
Clinical science (London, England : 1979) 1981;61(4):369-72.
-
1981: Moncada S; Vane J R
Prostacyclin: its biosynthesis, actions and clinical potential.
Philosophical transactions of the Royal Society of London. Series B, Biological sciences 1981;294(1072):305-29.
-
1981: Moncada S; Vane J R
Prostacyclin and blood coagulation.
Drugs 1981;21(6):430-7.
-
1981: Moncada S; Vane J R
Prostacyclin and the vascular endothelium.
Bulletin européen de physiopathologie respiratoire 1981;17(4):687-701.
-
1980: Mundy A R; Bewick M; Moncada S; Vane J R
Experimental assessment of prostacyclin in the harvesting of kidneys for transplantation.
Transplantation 1980;30(4):251-5.
-
1980: Vane J R
The research heritage of Henry Wellcome.
Pharmaceutical historian 1980;10(2):2-8.
-
1980: Higgs G A; Eakins K E; Mugridge K G; Moncada S; Vane J R
The effects of non-steroid anti-inflammatory drugs on leukocyte migration in carrageenin-induced inflammation.
European journal of pharmacology 1980;66(1):81-6.
-
1980: Woods H F; Weston M J; Bunting S; Moncada S; Vane J
Prostacyclin eliminates the thrombocytopenia associated with charcoal hemoperfusion and minimizes heparin and fibrinogen consumption.
Artificial organs 1980;4(3):176-9.
-
1980: Moncada S; Vane J R
Biological significance and therapeutic potential of prostacyclin.
Journal of medicinal chemistry 1980;23(6):591-3.
-
1980: Dusting G J; Vane J R
Some cardiovascular properties of prostacyclin (PGI2) which are not shared by PGE2.
Circulation research 1980;46(6 Pt 2):I183-7.
-
1980: Whittle B J; Moncada S; Whiting F; Vane J R
Carbacyclin--a potent stable prostacyclin analogue for the inhibition of platelet aggregation.
Prostaglandins 1980;19(4):605-27.
-
1980: Mundy A R; Bewick M; Moncada S; Vane J R
Short term suppression of hyperacute renal allograft rejection in presensitised dogs with prostacyclin.
Prostaglandins 1980;19(4):595-603.
-
1980: Whittle B J; Higgs G A; Eakins K E; Moncada S; Vane J R
Selective inhibition of prostaglandin production in inflammatory exudates and gastric mucosa.
Nature 1980;284(5753):271-3.
-
1980: Chapple D J; Dusting G J; Hughes R; Vane J R
Some direct and reflex cardiovascular actions of prostacyclin (PGI2) and prostaglandin E2 in anaesthetized dogs.
British journal of pharmacology 1980;68(3):437-47.
-
1980: Gryglewski R J; Vane J R
The evolution of ideas in prostaglandin research.
Materia medica Polona. Polish journal of medicine and pharmacy 1980;12(3):159-68.
-
1980: Vane J R; Moncada S
The anti-thrombotic effects of prostacyclin.
Acta medica Scandinavica. Supplementum 1980;642():11-22.
-
1980: Moncada S; Vane J R
Prostacyclin in the cardiovascular system.
Advances in prostaglandin and thromboxane research 1980;6():43-60.
-
1980: Vane J R
The Wellcome centenary. Henry S. Wellcome, his research philosophy and current excitements.
Transactions of the Medical Society of London 1980;97():41-50.
-
1980: Moncada S; Vane J R
Interrelationships between prostacyclin and thromboxane A2.
Ciba Foundation symposium 1980;78():165-83.
-
1980: Vane J R; Moncada S
Prostacyclin.
Ciba Foundation symposium 1980;71():79-97.
-
1980: Mullane K M; Moncada S; Vane J R
Prostacyclin release induced by bradykinin may contribute to the antihypertensive action of angiotensin-converting enzyme inhibitors.
Advances in prostaglandin and thromboxane research 1980;7():1159-61.
-
1980: Vane J R
Metabolic activities of the lung: introduction.
Ciba Foundation symposium 1980;78():1-10.
-
1979: Kauffman G L; Whittle B J; Aures D; Vane J R; Grossman M I
Effects of prostacyclin and a stable analogue, 6-beta-PGI1, on gastric acid secretion, mucosal blood flow, and blood pressure in conscious dogs.
Gastroenterology 1979;77(6):1301-6.
-
1979: Gryglewski R J; Salmon J A; Ubatuba F B; Weatherly B C; Moncada S; Vane J R
Effects of all cis-5,8,11,14,17 eicosapentaenoic acid and PGH3 on platelet aggregation.
Prostaglandins 1979;18(3):453-78.
-
1979: Higgs G A; Cardinal D C; Moncada S; Vane J R
Microcirculatory effects of prostacyclin (PGI2) in the hamster cheek pouch.
Microvascular research 1979;18(2):245-54.
-
1979: Herman A G; Claeys M; Moncada S; Vane J R
Biosynthesis of prostaglandin (PGI2) and 12L-hydroxy-5,8,10,14-eicosatetraenoic acid (HETE) by pericardium, pleura, peritoneum and aorta of the rabbit.
Prostaglandins 1979;18(3):439-52.
-
1979: Salmon J A; Mullane K M; Dusting G J; Moncada S; Vane J R
Elimination of prostacyclin (PGI2) and 6-oxo-PGF1 alpha in anaesthetized dogs.
The Journal of pharmacy and pharmacology 1979;31(8):529-32.
-
1979: Higgs G A; Flower R J; Vane J R
A new approach to anti-inflammatory drugs.
Biochemical pharmacology 1979;28(12):1959-61.
-
1979: Moncada S; Mullane K M; Vane J R
Prostacyclin-release by bradykinin in vivo [proceedings]
British journal of pharmacology 1979;66(1):96P-97P.
-
1979: Dusting G J; Moncada S; Vane J R
Prostaglandins, their intermediates and precursors: cardiovascular actions and regulatory roles in normal and abnormal circulatory systems.
Progress in cardiovascular diseases 1979;21(6):405-30.
-
1979: Moncada S; Vane J R
Arachidonic acid metabolites and the interactions between platelets and blood-vessel walls.
The New England journal of medicine 1979;300(20):1142-7.
-
1979: Longmore D B; Bennett G; Gueirrara D; Smith M; Bunting S; Moncada S; Reed P; Read N G; Vane J R
Prostacyclin: a solution to some problems of extracorporeal circulation. Experiments in greyhounds.
Lancet 1979;1(8124):1002-5.
-
1979: Ubatuba F B; Moncada S; Vane J R
The effect of prostacyclin (PGT2) on platelet behaviour. Thrombus formation in vivo and bleeding time.
Thrombosis and haemostasis 1979;41(2):425-35.
-
1979: Mullane K M; Dusting G J; Salmon J A; Moncada S; Vane J R
Biotransformation and cardiovascular effects of arachidonic acid in the dog.
European journal of pharmacology 1979;54(3):217-28.
-
1979: Vane J
Fats and atheroma: an inquest.
British medical journal 1979;1(6161):484-5.
-
1979: Moncada S; Vane J R
The role of prostacyclin in vascular tissue.
Federation proceedings 1979;38(1):66-71.
-
1979: Vane J R; Moncada S
Polyunsaturated fatty acids as precursors of prostaglandins.
Acta cardiologica. Supplementum 1979;(23):21-37.
-
1979: Moncada S; Vane J R
Mode of action of aspirin-like drugs.
Advances in internal medicine 1979;24():1-22.
-
1979: Higgs G A; Eakins K E; Moncada S; Vane J R
Arachidonic acid metabolism in inflammation and the mode of action of anti-inflammatory drugs.
Agents and actions. Supplements 1979;(6):167-75.
-
1979: Vane J R
Finding the resources to fight tropical diseases.
Transactions of the Royal Society of Tropical Medicine and Hygiene 1979;73(2):140-3.
-
1978: Dusting G J; Chapple D J; Hughes R; Moncada S; Vane J R
Prostacyclin (PGI2) induces coronary vasodilatation in anaesthetised dogs.
Cardiovascular research 1978;12(12):720-30.
-
1978: Herman A G; Claeys M; Moncada S; Vane J R
Prostacyclin production by rabbit aorta, pericardium, pleura, peritoneum and dura mater.
Archives internationales de pharmacodynamie et de thérapie 1978;236(2):303-4.
-
1978: Blackwell G J; Flower R J; Russell-Smith N; Salmon J A; Thorogood P B; Vane J R
1-n-Butylimidazole: a potent and selective inhibitor of 'thromboxane synthetase' [proceedings]
British journal of pharmacology 1978;64(3):435P.
-
1978: Blackwell G J; Flower R J; Russell-Smith N; Salmon J A; Thorogood P B; Vane J R
Prostacyclin is produced in whole blood [proceedings]
British journal of pharmacology 1978;64(3):436P.
-
1978: Woods H F; Ash G; Weston M J; Bunting S; Moncada S; Vane J R
Prostacyclin can replace heparin in haemodialysis in dogs.
Lancet 1978;2(8099):1075-7.
-
1978: Dusting G J; Moncada S; Vane J R
Recirculation of prostacyclin (PGI2) in the dog.
British journal of pharmacology 1978;64(2):315-20.
-
1978: Whittle B J; Moncada S; Vane J R
Comparison of the effects of prostacyclin (PGI2), prostaglandin E1 and D2 on platelet aggregation in different species.
Prostaglandins 1978;16(3):373-88.
-
1978: Moncada S; Vane J R
Pharmacology and endogenous roles of prostaglandin endoperoxides, thromboxane A2, and prostacyclin.
Pharmacological reviews 1978;30(3):293-331.
-
1978: Whittle B J; Boughton-Smith N K; Moncada S; Vane J R
The relative activity of prostacyclin (PGI2) and a stable analogue 6beta-PGI1 on the gastrointestinal and cardiovascular systems.
The Journal of pharmacy and pharmacology 1978;30(9):597-9.
-
1978: Higgs E A; Moncada S; Vane J R
Inflammatory effects of prostacyclin (PGI2) and 6-oxo-PGF1alpha in the rat paw.
Prostaglandins 1978;16(2):153-62.
-
1978: Chapple D J; Dusting G J; Hughes R; Vane J R
A vagal reflex contributes to the hypotensive effect of prostacyclin in anaesthetized dogs [proceedings]
The Journal of physiology 1978;281():43P-44P.
-
1978: Higgs E A; Moncada S; Vane J R; Caen J P; Michel H; Tobelem G
Effect of prostacyclin (PGI2) on platelet adhesion to rabbit arterial subendothelium.
Prostaglandins 1978;16(1):17-22.
-
1978: Higgs G A; Moncada S; Vane J R
Prostacyclin reduces the number of 'slow moving' leucocytes in hamster cheek pouch venules [proceedings]
The Journal of physiology 1978;280():55P-56P.
-
1978: Higgs E A; Higgs G A; Moncada S; Vane J R
Prostacyclin (PGI2) inhibits the formation of platelet thrombi in arterioles and venules of the hamster cheek pouch.
British journal of pharmacology 1978;63(3):535-9.
-
1978: Dyerberg J; Bang H O; Stoffersen E; Moncada S; Vane J R
Eicosapentaenoic acid and prevention of thrombosis and atherosclerosis?
Lancet 1978;2(8081):117-9.
-
1978: Dusting G J; Moncada S; Mullane K M; Vane J R
Biotransformation of arachidonic acid in the circulation of the dog [proceedings]
British journal of pharmacology 1978;63(2):359P.
-
1978: Whittle B J; Boughton-Smith N K; Moncada S; Vane J R
Actions of prostacyclin (PGI2) and its product, 6-oxo-PGF1alpha on the rat gastric mucosa in vivo and in vitro.
Prostaglandins 1978;15(6):955-67.
-
1978: Moncada S; Korbut R; Bunting S; Vane J R
Prostacyclin is a circulating hormone.
Nature 1978;273(5665):767-8.
-
1978: Vane J R
The mode of action of aspirin-like drugs.
Agents and actions 1978;8(4):430-1.
-
1978: Dusting G J; Moncada S; Vane J R
Vascular actions of arachidonic acid and its metabolites in perfused mesenteric and femoral beds of the dog.
European journal of pharmacology 1978;49(1):65-72.
-
1978: Moncada S; Vane J R
Unstable metabolites of arachidonic acid and their role in haemostasis and thrombosis.
British medical bulletin 1978;34(2):129-35.
-
1978: Herman A G; Verbeuren T J; Moncada S; Vane J R; Vanhoutte P M
Effect of prostacyclin on myogenic activity and adrenergic neuroeffector interaction in isolated canine veins.
Archives internationales de pharmacodynamie et de thérapie 1978;232(2):340-1.
-
1978: Bunting S; Moncada S; Reed P; Salmon J A; Vane J R
An antiserum to 5,6-dihydro prostacyclin (PGI1) which also binds prostacyclin.
Prostaglandins 1978;15(4):565-73.
-
1978: Salmon J A; Smith D R; Flower R J; Moncada S; Vane J R
Further studies on the enzymatic conversion of prostaglandin endoperoxide into prostacyclin by porcine aorta microsomes.
Biochimica et biophysica acta 1978;523(1):250-62.
-
1978: Dusting G J; Moncada S; Vane J R
Disappearance of prostacyclin (PGI2) in the circulation of the dog [proceedings]
British journal of pharmacology 1978;62(3):414P-415P.
-
1978: Boughton-Smith N K; Vane J R; Whittle B J
Effects of prostacyclin (PGI2), PGI1 and 6-oxo-PGF1alpha on the rat gastric mucosa [proceedings]
British journal of pharmacology 1978;62(3):413P.
-
1978: Moncada S; Salmon J A; Vane J R; Whittle B J
Formation of prostacyclin and its product 6-oxo-PGF1alpha by the gastric mucosa of several species [proceedings]
The Journal of physiology 1978;275():4P-5P.
-
1978: Higgs G A; Moncada S; Vane J R
Prostacyclin as a potent dilator of arterioles in the hamster cheek pouch [proceedings]
The Journal of physiology 1978;275():30P-31P.
-
1978: Blackwell G J; Flower R J; Nijkamp F P; Vane J R
Phospholipase A2 activity of guinea-pig isolated perfused lungs: stimulation, and inhibition by anti-inflammatory steroids.
British journal of pharmacology 1978;62(1):79-89.
-
1978: Armstrong J M; Lattimer N; Moncada S; Vane J R
Comparison of the vasodepressor effects of prostacyclin and 6-oxo-prostaglandin F1alpha with those of prostaglandin E2 in rats and rabbits.
British journal of pharmacology 1978;62(1):125-30.
-
1978: Schrör K; Moncada S; Ubatuba F B; Vane J R
Transformation of arachidonic acid and prostaglandin endoperoxides by the guinea pig heart. Formation of RCS and prostacyclin.
European journal of pharmacology 1978;47(1):103-14.
-
1978: Moncada S; Ferreira S H; Vane J R
Bioassay of prostaglandins and biologically active substances derived from arachidonic acid.
Advances in prostaglandin and thromboxane research 1978;5():211-36.
-
1978: Vane J R
Inhibitors of prostaglandin, prostacyclin, and thromboxane synthesis.
Advances in prostaglandin and thromboxane research 1978;4():27-44.
-
1978: Whittle B J; Moncada S; Vane J R
Some actions of prostacyclin (PGI2) on the cardiovascular system and the gastric microcirculation.
Acta biologica et medica Germanica 1978;37(5-6):725-8.
-
1977: Moncada S; Vane J R; Whittle B J
Relative potency of prostacyclin, prostaglandin E1 and D2 as inhibitors of platelet aggregation in several species [proceedings]
The Journal of physiology 1977;273(2):2P-4P.
-
1977: Bunting S; Moncada S; Vane J R
Antithrombotic properties of vascular endothelium.
Lancet 1977;2(8047):1075-6.
-
1977: Vane J R
Pharmaceutical research and the world's health.
Tropical doctor 1977;7(4):186-8.
-
1977: Omini C; Moncada S; Vane J R
The effects of prostacyclin (PGI2) on tissues which detect prostaglandins (PG'S).
Prostaglandins 1977;14(4):625-32.
-
1977: Dusting G J; Moncada S; Vane J R
Prostacyclin (PGI2) is a weak contractor of coronary arteries of the pig.
European journal of pharmacology 1977;45(3):301-4.
-
1977: Cottee F; Flower R J; Moncada S; Salmon J A; Vane J R
Synthesis of 6-keto-PGF1alpha by ram seminal vesicle microsomes.
Prostaglandins 1977;14(3):413-23.
-
1977: Moncada S; Herman A G; Higgs E A; Vane J R
Differential formation of prostacyclin (PGX or PGI2) by layers of the arterial wall. An explanation for the anti-thrombotic properties of vascular endothelium.
Thrombosis research 1977;11(3):323-44.
-
1977: Higgs G A; Moncada S; Vane J R
Prostacyclin (PGI2) inhibits the formation of platelet thrombi induced by adenosine diphosphate (ADP) in vivo [proceedings]
British journal of pharmacology 1977;61(1):137P.
-
1977: Armstrong J M; Chapple D; Dusting G J; Hughes R; Moncada S; Vane J R
Cardiovascular actions of prostacyclin (PCI2) in chloralose anaesthetized dogs [proceedings]
British journal of pharmacology 1977;61(1):136P.
-
1977: Beddell C R; Clark R B; Hardy G W; Lowe L A; Ubatuba F B; Vane J R; Wilkinson S
Structural requirements for opioid activity of analogues of the enkephalins.
Proceedings of the Royal Society of London. Series B, Containing papers of a Biological character. Royal Society (Great Britain) 1977;198(1132):249-65.
-
1977: Nijkamp F P; Moncada S; White H L; Vane J R
Diversion of prostaglandin endoperoxide metabolism by selective inhibition of thromboxane A2 biosynthesis in lung, spleen or platelets.
European journal of pharmacology 1977;44(2):179-86.
-
1977: Herman A G; Moncada S; Vane J R
Formation of prostacyclin (PGl2) by different layers of the arterial wall.
Archives internationales de pharmacodynamie et de thérapie 1977;227(1):162-3.
-
1977: Moncada S; Bunting S; Mullane K; Thorogood P; Vane J R; Raz A; Needleman P
Imidazole: a selective inhibitor of thromboxane synthetase.
Prostaglandins 1977;13(4):611-8.
-
1977: Dusting G J; Lattimer N; Moncada S; Vane J R
Prostaglandin X, the vascular metabolite of arachidonic acid responsible for relaxation of bovine coronary artery strips [proceedings].
British journal of pharmacology 1977;59(3):443P.
-
1977: Blackwell G J; Flower R J; Nijkamp F P; Vane J R
Phospholipase A2 activity of guinea-pig perfused lungs: stimulation and inhibition by anti-inflammatory steroids [proceedings].
British journal of pharmacology 1977;59(3):441P.
-
1977: Tateson J E; Moncada S; Vane J R
Effects of prostacyclin (PGX) on cyclic AMP concentrations in human platelets.
Prostaglandins 1977;13(3):389-97.
-
1977: Blackwell G J; Duncombe W G; Flower R J; Parsons M F; Vane J R
The distribution and metabolism of arachidonic acid in rabbit platelets during aggregation and its modification by drugs.
British journal of pharmacology 1977;59(2):353-66.
-
1977: Dusting G J; Moncada S; Vane J R
Prostacyclin (PGX) is the endogenous metabolite responsible for relaxation of coronary arteries induced by arachindonic acid.
Prostaglandins 1977;13(1):3-15.
-
1977: Moncada S; Higgs E A; Vane J R
Human arterial and venous tissues generate prostacyclin (prostaglandin x), a potent inhibitor of platelet aggregation.
Lancet 1977;1(8001):18-20.
-
1977: Vane J R
The place of fundamental research in the discovery of new drugs.
Triangle; the Sandoz journal of medical science 1977;16(3-4):119-22.
-
1977: Moncada S; Vane J R
Interaction between anti-inflammatory drugs and inflammatory mediators. A reference to products of arachidonic acid metabolism.
Agents and actions. Supplements 1977;(3):141-8.
-
1977: Vane J R
[Perspectives in science]
Przegla¸d lekarski 1977;34(12):833-6.
-
1976: Bunting S; Gryglewski R; Moncada S; Vane J R
Arterial walls generate from prostaglandin endoperoxides a substance (prostaglandin X) which relaxes strips of mesenteric and coeliac ateries and inhibits platelet aggregation.
Prostaglandins 1976;12(6):897-913.
-
1976: Vane J R
The mode of action of aspirin and similar compounds.
The Journal of allergy and clinical immunology 1976;58(6):691-712.
-
1976: Whittaker N; Bunting S; Salmon J; Moncada S; Vane J R; Johnson R A; Morton D R; Kinner J H; Gorman R R; McGuire J C; Sun F F
The chemical structure of prostaglandin X (prostacyclin).
Prostaglandins 1976;12(6):915-28.
-
1976: Higgs G A; Bunting S; Moncada S; Vane J R
Polymorphonuclear leukocytes produce thromboxane A2-like activity during phagocytosis.
Prostaglandins 1976;12(5):749-57.
-
1976: Moncada S; Gryglewski R J; Bunting S; Vane J R
A lipid peroxide inhibits the enzyme in blood vessel microsomes that generates from prostaglandin endoperoxides the substance (prostaglandin X) which prevents platelet aggregation.
Prostaglandins 1976;12(5):715-37.
-
1976: Gryglewski R J; Bunting S; Moncada S; Flower R J; Vane J R
Arterial walls are protected against deposition of platelet thrombi by a substance (prostaglandin X) which they make from prostaglandin endoperoxides.
Prostaglandins 1976;12(5):685-713.
-
1976: Bunting S; Higgs G A; Moncada S; Vane J R
Generation of thromboxane A2-like activity from prostaglandin endoperoxides by polymorphonuclear leukocyte homogenates [proceedings].
British journal of pharmacology 1976;58(2):296P.
-
1976: Nijkamp F P; Flower R J; Moncada S; Vane J R
Partial purification of rabbit aorta contracting substance-releasing factor and inhibition of its activity by anti-inflammatory steroids.
Nature 1976;263(5577):479-82.
-
1976: Moncada S; Gryglewski R; Bunting S; Vane J R
An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation.
Nature 1976;263(5579):663-5.
-
1976: Moncada S; Needleman P; Bunting S; Vane J R
Prostaglandin endoperoxide and thromboxane generating systems and their selective inhibition.
Prostaglandins 1976;12(3):323-35.
-
1976: Herman A G; Vane J R
Release of renal prostaglandins during endotoxin-induced hypotension.
European journal of pharmacology 1976;39(1):79-90.
-
1976: Bunting S; Moncada S; Vane J R
The effects of prostagladin endoperoxides and thromboxane A2 on strips of rabbit coeliac artery and certain other smooth muscle preparations [proceedings].
British journal of pharmacology 1976;57(3):462P-463P.
-
1976: Flower R J; Harvey E A; Moncada S; Nijkamp F P; Vane J R
Some properties of rabbit aorta contracting substance-releasing factor (RCS-RF) [proceedings].
British journal of pharmacology 1976;57(3):461P-462P.
-
1976: Needleman P; Moncada S; Bunting S; Vane J R; Hamberg M; Samuelsson B
Identification of an enzyme in platelet microsomes which generates thromboxane A2 from prostaglandin endoperoxides.
Nature 1976;261(5561):558-60.
-
1976: Staszewka-Barczak J; Ferreira S H; Vane J R
An excitatory nociceptive cardiac reflex elicited by bradykinin and potentiated by prostaglandins and myocardial ischaemia.
Cardiovascular research 1976;10(3):314-27.
-
1976: Armstrong J M; Blackwell G J; Flower R J; McGiff J C; Mullane K M; Vane J R
Genetic hypertension in rats is accompanied by a defect in renal prostaglandin catabolism.
Nature 1976;260(5552):582-6.
-
1976: Ferreira S H; Herman A G; Vane J R
Prostaglandin production by rabbit isolated jejunum and its relationship to the inherent tone of the preparation.
British journal of pharmacology 1976;56(4):469-77.
-
1976: Bunting S; Moncada S; Needleman P; Vane J R
Proceedings: Formation of prostaglandin endoperoxides and rabbit aorta contracting substance (RCS) by coupling two enzyme systems.
British journal of pharmacology 1976;56(3):344P-345P.
-
1976: Ferreira S H; Ubatuba F B; Vane J R
Platelets, acute inflammation and inflammatory mediators.
Agents and actions 1976;6(1-3):313-7.
-
1976: Higgs G A; Harvey E A; Ferreira S H; Vane J R
The effects of antiinflammatory drugs on the production of prostaglandins in vivo.
Advances in prostaglandin and thromboxane research 1976;1():105-10.
-
1976: Vane J R
Prostaglandins as mediators of inflammation.
Advances in prostaglandin and thromboxane research 1976;2():791-801.
-
1976: Herman A G; Vane J R
Effect of indomethacin on endotoxin-induced production of prostaglandins in the isolated rabbit jejunum.
Advances in prostaglandin and thromboxane research 1976;2():557-60.
-
1975: Blackwell G J; Flower R J; Vane J R
Rapid reduction of prostaglandin 15-hydroxy dehydrogenase activity in rat tissues after treatment with protein synthesis inhibitors.
British journal of pharmacology 1975;55(2):233-8.
-
1975: McGiff J C; Vane J R
Prostaglandins and the regulation of blood pressure.
Kidney international. Supplement 1975;():S262-70.
-
1975: Keyes M J; Vane J R
The effects of vicarious reinforcement on modeling by schizophrenic hospital patients.
Journal of clinical psychology 1975;31(3):413-5.
-
1975: Blackwell G J; Flower R J; Vane J R
Some characteristics of the prostaglandin synthesizing system in rabbit kidney microsomes.
Biochimica et biophysica acta 1975;398(1):178-90.
-
1975: Vane J R; McGiff J C
Possible contributions of endogenous prostaglandins to the control of blood pressure.
Circulation research 1975;36(6 Suppl 1):68-75.
-
1975: Moncada S; Ferreira S H; Vane J R
Inhibition of prostaglandin biosynthesis as the mechanism of analgesia of aspirin-like drugs in the dog knee joint.
European journal of pharmacology 1975;31(2):250-60.
-
1975: Vane J R
Thorne's theory: hypothesis testing and the diagnosis of personality states.
Journal of clinical psychology 1975;31(2):198-201.
-
1975: Blackwell G J; Flower R J; Parsons M F; Vane J R
Factors influencing the turnover of prostaglandin synthetase.
British journal of pharmacology 1975;53(3):467P-468P.
-
1975: Herman A G; Vane J R
Endotoxin and production of prostaglandins by the isolated rabbit jejunum. Influence of indomethacin.
Archives internationales de pharmacodynamie et de thérapie 1975;213(2):328-9.
-
1975: Block A J; Feinberg H; Herbaczynska-Cedro K; Vane J R
Anoxia-induced release of prostaglandins in rabbit isolated hearts.
Circulation research 1975;36(1):34-5.
-
1975: Staszewska-Barczak J; Vane J R
The role of prostaglandins in the local control of circulation.
Clinical and experimental pharmacology & physiology 1975;Suppl 2():71-8.
-
1975: Williams K I; Vane J R
Inhibition of uterine motility: the possible role of the prostaglandins and aspirin-like drugs.
Pharmacology & therapeutics. Part B: General & systematic pharmacology 1975;1(1):89-113.
-
1974: Ferreira S H; Flower R J; Parsons M F; Vane J R
Letter: Reduction of the inflammatory response in rats immunized against prostaglandins.
Prostaglandins 1974;8(5):433-7.
-
1974: Vane J R; Williams K I
A sensitive method for the assay of oxytocin in the circulating blood.
British journal of pharmacology 1974;52(2):295-305.
-
1974: Bakhle Y S; Vane J R
Pharmacokinetic function of the pulmonary circulation.
Physiological reviews 1974;54(4):1007-45.
-
1974: Ferreira S H; Moncada S; Parsons M; Vane J R
Proceedings: the concomitant release of bradykinin and prostaglandin in the inflammatory response to carrageenin.
British journal of pharmacology 1974;52(1):108P-109P.
-
1974: Leary W P; Ledingham J G; Vane J R
Impaired prostaglandin release from the kidneys of salt-loaded and hypertensive rats.
Prostaglandins 1974;7(5):425-32.
-
1974: Block A J; Poole S; Vane J R
Modification of basal release of prostaglandins from rabbit isolated hearts.
Prostaglandins 1974;7(6):473-86.
-
1974: Flower R J; Vane J R
Inhibition of prostaglandin biosynthesis.
Biochemical pharmacology 1974;23(10):1439-50.
-
1974: Herman A G; Vane J R
On the mechanism of the release of prostaglandins E2 and F2 alpha in renal venous blood during endotoxin-hypotension.
Archives internationales de pharmacodynamie et de thérapie 1974;208(2):365-6.
-
1974: Ferreira S H; Moncada S; Vane J R
Proceedings: Potentiation by prostaglandins of the nociceptive activity of bradykinin in the dog knee joint.
British journal of pharmacology 1974;50(3):461P.
-
1974: Cross S A; Alabaster V A; Bakhle Y S; Vane J R
Sites of uptake of 3H-5-hydroxytryptamine in rat isolated lung.
Histochemistry 1974;39(1):83-91.
-
1974: Herbaczynska-Cedro K; Vane J R
Prostaglandins as mediators of reactive hyperaemia in kidney.
Nature 1974;247(441):492.
-
1974: Moncada S; Ferreira S H; Vane J R
The blockade of the local generation of prostaglandins explains the analgesic action of aspirin.
Polish journal of pharmacology and pharmacy 1974;26(1):77.
-
1973: Ferreira S H; Moncada S; Vane J R
The blockade of the local generation of prostaglandins explains the analgesic action of aspirin.
Agents and actions 1973;3(5):385.
-
1973: Higgs G A; Vane J R
An improved method for the extraction of prostaglandins.
Prostaglandins 1973;4(5):695-9.
-
1973: Ferreira S H; Ng K K; Vane J R
The continuous bioassay of the release and disappearance of histamine in the circulation.
British journal of pharmacology 1973;49(3):543-53.
-
1973: Moncada S; Ferreira S H; Vane J R
Prostaglandins, aspirin-like drugs and the oedema of inflammation.
Nature 1973;246(5430):217-9.
-
1973: Herbaczynska-Cedro K; Vane J R
Contribution of intrarenal generation of prostaglandin to autoregulation of renal blood flow in the dog.
Circulation research 1973;33(4):428-36.
-
1973: Palmer M A; Piper P J; Vane J R
Release of rabbit aorta contracting substance (RCS) and prostaglandins induced by chemical or mechanical stimulation of guinea-pig lungs.
British journal of pharmacology 1973;49(2):226-42.
-
1973: Ferreira S H; Moncada S; Vane J R
Prostaglandins and the mechanism of analgesia produced by aspirin-like drugs.
British journal of pharmacology 1973;49(1):86-97.
-
1973: Vane J R; Williams K I
The contribution of prostaglandin production to contractions of the isolated uterus of the rat.
British journal of pharmacology 1973;48(4):629-39.
-
1973: Collier J G; Herman A G; Vane J R
Appearance of prostaglandins in the renal venous blood of dogs in response to acute systemic hypotension produced by bleeding or endotoxin.
The Journal of physiology 1973;230(1):19P-20P.
-
1973: Eble J N; Gowdey C W; Rudzik A D; Vane J R
Study of the mechanisms of the modifying actions of hexamethonium on the cardiovascular response to norepinephrine.
The Journal of pharmacology and experimental therapeutics 1973;184(3):649-55.
-
1973: Aiken J W; Vane J R
Intrarenal prostaglandin release attenuates the renal vasoconstrictor activity of angiotensin.
The Journal of pharmacology and experimental therapeutics 1973;184(3):678-87.
-
1973: Ferreira S H; Moncada S; Vane J R
Further experiments to establish that the analgesic action of aspirin-like drugs depends on the inhibition of prostaglandin biosynthesis.
British journal of pharmacology 1973;47(3):629P-630P.
-
1973: Ferreira S H; Moncada S; Vane J R
Some effects of inhibiting endogenous prostaglandin formation on the responses of the cat spleen.
British journal of pharmacology 1973;47(1):48-58.
-
1973: Collier J G; Robinson B F; Vane J R
Reduction of pressor effects of angiotensin I in man by synthetic nonapeptide (B.P.P. 9a or SQ 20,881) which inhibits converting enzyme.
Lancet 1973;1(7794):72-4.
-
1972: Flower R J; Vane J R
Inhibition of prostaglandin synthetase in brain explains the anti-pyretic activity of paracetamol (4-acetamidophenol).
Nature 1972;240(5381):410-1.
-
1972: Gryglewski R; Vane J R
The generation from arachidonic acid of rabbit aorta contracting substance (RCS) by a microsomal enzyme preparation which also generates prostaglandins.
British journal of pharmacology 1972;46(3):449-57.
-
1972: Eble J N; Gowdey C W; Vane J R
Blood concentrations of adrenaline in dogs after intravenous administration of 5-hydroxytryptamine.
Nature: New biology 1972;238(86):254-6.
-
1972: Eckenfels A; Vane J R
Prostaglandins, oxygen tension and smooth muscle tone.
British journal of pharmacology 1972;45(3):451-62.
-
1972: Flower R; Gryglewski R; Herbaczynska-Cedro K; Vane J R
Effects of anti-inflammatory drugs on prostaglandin biosynthesis.
Nature: New biology 1972;238(82):104-6.
-
1972: Gryglewski R; Vane J R
The release of prostaglandins and rabbit aorta contracting substance (RCS) from rabbit spleen and its antagonism by anti-inflammatory drugs.
British journal of pharmacology 1972;45(1):37-47.
-
1972: Vane J R; Williams K I
Prostaglandin production contributes to the contractions of the rat isolated uterus.
British journal of pharmacology 1972;45(1):146P.
-
1972: Aiken J W; Vane J R
Inhibition of converting enzyme of the renin-angiotensin system in kidneys and hindlegs of dogs.
Circulation research 1972;30(3):263-73.
-
1972: Ferreira S H; Herman A; Vane J R
Proceedings: Prostaglandin generation maintains the smooth muscle tone of the rabbit isolated jejunum.
British journal of pharmacology 1972;44(2):328P-329P.
-
1971: Gryglewski R; Vane J R
Rabbit-aorta contracting substance (RCS) may be a prostaglandin precursor.
British journal of pharmacology 1971;43(2):420P-421P.
-
1971: Pojda S M; Vane J R
Inhibitory effects of aprotinin on kallikrein and kininases in dog's blood.
British journal of pharmacology 1971;42(4):558-68.
-
1971: Gilmore N J; Vane J R
Hormones released into the circulation when the urinary bladder of the anaesthetized dog is distended.
Clinical science 1971;41(1):69-83.
-
1971: Ferreira S H; Moncada S; Vane J R
Indomethacin and aspirin abolish prostaglandin release from the spleen.
Nature: New biology 1971;231(25):237-9.
-
1971: Vane J R
Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs.
Nature: New biology 1971;231(25):232-5.
-
1971: Eble J N; Gowdey C W; Vane J R
Blood concentration of noradrenaline in the dog after intravenous administration and the effects of desipramine.
Nature 1971;231(5299):181-2.
-
1971: Vane J R
Purity and stability of synthetic peptides such as angiotensins and kinins.
Nature 1971;230(5293):382.
-
1971: Piper P; Vane J
The release of prostaglandins from lung and other tissues.
Annals of the New York Academy of Sciences 1971;180():363-85.
-
1971: Vane J R
Mediators of the anaphylactic reaction.
Ciba Foundation study group 1971;38():121-31.
-
1970: Palmer M A; Piper P J; Vane J R
The release of rabbit aorta contracting substance (RCS) from chopped lung and its antagonism by anti-inflammatory drugs.
British journal of pharmacology 1970;40(3):581P-582P.
-
1970: Palmer M A; Piper P J; Vane J R
Release of vaso-active substances from lungs by injection of particles.
British journal of pharmacology 1970;40(3):547P-548P.
-
1970: Aiken J W; Vane J R
The renin--angiotensin system: inhibition of converting enzyme in isolated tissues.
Nature 1970;228(5266):30-4.
-
1970: Berry H E; Collier J G; Vane J R
The generation of kinins in the blood of dogs during hypotension due to haemorrhage.
Clinical science 1970;39(3):349-65.
-
1970: Gryglewski R; Vane J R
The inactivation of noradrenaline and isoprenaline in dogs.
British journal of pharmacology 1970;39(3):573-84.
-
1970: Hughes J; Vane J R
Relaxations of the isolated portal vein of the rabbit induced by nicotine and electrical stimulation.
British journal of pharmacology 1970;39(3):476-89.
-
1970: Eble J N; Gowdey C W; Vane J R
The potentiation of the cardiovascular responses of the dog to noradrenaline by desmethylimipramine.
British journal of pharmacology 1970;39(1):185P-186P.
-
1970: Gilore N J; Vane J R
A sensitive and specific assay for vasopressin in the circulating blood.
British journal of pharmacology 1970;38(4):633-52.
-
1970: Piper P J; Said S I; Vane J R
Effects on smooth muscle preparations of unidentified vasoactiv peptides from intestine and lung.
Nature 1970;225(5238):1144-6.
-
1970: Ng K K; Vane J R
Some properties of angiotensin converting enzyme in the lung in vivo.
Nature 1970;225(5238):1142-4.
-
1970: Vane J R; Williams K I
A sensitive method for the assay of oxytocin in blood.
British journal of pharmacology 1970;38(2):444P-445P.
-
1970: Piper P J; Vane J R; Wyllie J H
Inactivation of prostaglandins by the lungs.
Nature 1970;225(5233):600-4.
-
1970: Ferreira S H; Greene L H; Alabaster V A; Bakhle Y S; Vane J R
Activity of various fractions of bradykinin potentiating factor against angiotensin I converting enzyme.
Nature 1970;225(5230):379-80.
-
1969: Hodge R L; Lowe R D; Vane J R
The role of circulating catecholamines in arterial baroceptor reflexes in the dog and in man.
Clinical science 1969;37(1):69-77.
-
1969: Wyllie J H; Piper P J; Vane J R
Fate of prostaglandins in the lungs.
The British journal of surgery 1969;56(8):623.
-
1969: Ferreira S H; Gollub L R; Vane J R
The release of catecholamines by shocks and stimuli paired with shocks.
Journal of the experimental analysis of behavior 1969;12(4):623-31.
-
1969: Vane J R
The dynamics of the renin-angiotensin system.
Proceedings of the Royal Society of London. Series B, Containing papers of a Biological character. Royal Society (Great Britain) 1969;173(32):339-40.
-
1969: Piper P J; Vane J R
Release of additional factors in anaphylaxis and its antagonism by anti-inflammatory drugs.
Nature 1969;223(5201):29-35.
-
1969: Bakhle Y S; Reynard A M; Vane J R
Metabolism of the angiotensins in isolated perfused tissues.
Nature 1969;222(5197):956-9.
-
1969: Vane J R
The release and fate of vaso-active hormones in the circulation.
British journal of pharmacology 1969;35(2):209-42.
-
1969: Hodge R L; Lowe R D; Ng K K; Vane J R
Role of the vagus nerve in the control of the concentration of angiotensin II in the circulation.
Nature 1969;221(5176):177-9.
-
1968: Ginn R; Vane J R
Disappearance of catecholamines from the circulation.
Nature 1968;219(5155):740-2.
-
1968: Duke H N; Vane J R
An adverse effect of polyvinylchloride tubing used in extracorporeal circulation.
Lancet 1968;2(7558):21-3.
-
1968: Gilmore N; Vane J R; Wyllie J H
Prostaglandins released by the spleen.
Nature 1968;218(5147):1135-40.
-
1968: Vane J R
The Vane kindergarten test.
Journal of clinical psychology 1968;24(2):121-54.
-
1968: Ng K K; Vane J R
Fate of angiotensin I in the circulation.
Nature 1968;218(5137):144-50.
-
1968: Vane J R
The release and assay of hormones in the circulation.
The Scientific basis of medicine annual reviews 1968;():336-58.
-
1968: Ng K K; Vane J R
The conversion of angiotensin I to angiotensin II in vivo.
Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie 1968;259(2):188-9.
-
1967: Ferreira S H; Vane J R
Prostaglandins: their disappearance from and release into the circulation.
Nature 1967;216(5118):868-73.
-
1967: Bennett A; Friedmann C A; Vane J R
Release of prostaglandin E-1 from the rat stomach.
Nature 1967;216(5118):873-6.
-
1967: Marley E; Vane J R
Tryptamines and spinal cord reflexes in cats.
British journal of pharmacology and chemotherapy 1967;31(3):447-65.
-
1967: Ng K K; Vane J R
Conversion of angiotensin I to angiotensin II.
Nature 1967;216(5117):762-6.
-
1967: Thomas D P; Vane J R
5-hydroxytryptamine in the circulation of the dog.
Nature 1967;216(5113):335-8.
-
1967: Ferreira S H; Vane J R
Half-lives of peptides and amines in the circulation.
Nature 1967;215(5107):1237-40.
-
1967: Staszewska-Barczak J; Vane J R
The release of catecholamines from the adrenal medulla by peptides.
British journal of pharmacology and chemotherapy 1967;30(3):655-67.
-
1967: Brown J J; Lever A F; Robertson J I; Hodge R L; Lowe R D; Vane J R
Concurrent measurement of renin and angiotensin in the circulation of the dog.
Nature 1967;215(5103):853-5.
-
1967: Vane J R
An evaluation of the Harris revision of the Goodenough draw-a-man Test.
Journal of clinical psychology 1967;23(3):375-7.
-
1967: Hodge R L; Ng K K; Vane J R
Disappearance of angiotensin from the circulation of the dog.
Nature 1967;215(5097):138-41.
-
1967: Ferreira S H; Vane J R
The disappearance of bradykinin and eledoisin in the circulation and vascular beds of the cat.
British journal of pharmacology and chemotherapy 1967;30(2):417-24.
-
1967: Mikos E; Vane J R
Effects of gastrin and its analogues on isolated smooth muscles.
Nature 1967;214(5083):105-7.
-
1967: Ferreira S H; Vane J R
The detection and estimation of bradykinin in the circulating blood.
British journal of pharmacology and chemotherapy 1967;29(3):367-77.
-
1967: Piper P J; Vane J R
The assay of catecholamines released into the circulation of the guinea-pig by angiotensin.
The Journal of physiology 1967;188(2):20P-21P.
-
1967: Hearst E; Vane J R
Some effects of d-amphetamine on the behavior of pigeons under intermittent reinforcement.
Psychopharmacologia 1967;12(1):58-67.
-
1966: Vane J R; Weitzman J; Applebaum A P
Performance of Negro and white children and problem and nonproblem children on the Stanford Binet scale.
Journal of clinical psychology 1966;22(4):431-5.
-
1966: Smith D J; Vane J R
Effects of oxygen tension on vascular and other smooth muscle.
The Journal of physiology 1966;186(2):284-94.
-
1966: Hodge R L; Lowe R D; Vane J R
The effects of alteration of blood-volume on the concentration of circulating angiotensin in anaesthetized dogs.
The Journal of physiology 1966;185(3):613-26.
-
1966: Hodge R L; Lowe R D; Vane J R
Increased angiotensin formation in response to carotid occlusion in the dog.
Nature 1966;211(5048):491-3.
-
1966: Regoli D; Vane J R
The continuous estimation of angiotensin formed in the circulation of the dog.
The Journal of physiology 1966;183(3):513-31.
-
1966: Vane J R
The estimation of catecholamines by biological assay.
Pharmacological reviews 1966;18(1):317-24.
-
1965: Staszewska-Barczak J; Vane J R
The release of catechol amines from the adrenal medulla by histamine.
British journal of pharmacology and chemotherapy 1965;25(3):728-42.
-
1964: VANE J R; KESSLER R T
THE GOODENOUGH DRAW-A-MAN TEST: LONG TERM RELIABILITY AND VALIDITY.
Journal of clinical psychology 1964;20():487-8.
-
1964: VANE J R
THE USE OF ISOLATED ORGANS FOR DETECTING ACTIVE SUBSTANCES IN THE CIRCULATING BLOOD.
British journal of pharmacology and chemotherapy 1964;23():360-73.
-
1964: REGOLI D; VANE J R
A SENSITIVE METHOD FOR THE ASSAY OF ANGIOTENSIN.
British journal of pharmacology and chemotherapy 1964;23():351-9.
-
1964: ARMITAGE A K; VANE J R
A SENSITIVE METHOD FOR THE ASSAY OF CATECHOL AMINES.
British journal of pharmacology and chemotherapy 1964;22():204-10.
-
1963: DAY M; VANE J R
An analysis of the direct and indirect actions of drugs on the isolated guinea-pig ileum.
British journal of pharmacology and chemotherapy 1963;20():150-70.
-
1963: PATON W D; VANE J R
Analysis of he responses of the isolated stomach to electrical stimulation and to drugs.
The Journal of physiology 1963;165():10-46.
-
1962: GELDER M G; VANE J R
Interaction of the effects of tyramine, amphetamine and reserprine in man.
Psychopharmacologia 1962;3():231-41.
-
1962: VANE J R; EISEN V W
The Goodenough draw-a-man test and signs of maladjustment in kindergarten children.
Journal of clinical psychology 1962;18():276-9.
-
1961: CLARK C G; VANE J R
The cardiac sphincter in the cat.
Gut 1961;2():252-62.
-
1961: VANE J R; COLLIER H O; CORNE S J; MARLEY E; BRADLEY P B
Tryptamine receptors in the central nervous system.
Nature 1961;191():1068-9.
-
1959: VANE J R
The relative activities of some tryptamine analogues on the isolated rat stomach strip preparation.
British journal of pharmacology and chemotherapy 1959;14(1):87-98.
-
1958: MARLEY E; VANE J R
The distribution of methylpentynol and of methylpentynol carbamate in tissues and body fluids of cats.
British journal of pharmacology and chemotherapy 1958;13(4):364-71.
-
1958: LAJTHA L G; VANE J R
Dependence of bone marrow cells on the liver for purine supply.
Nature 1958;182(4629):191-2.
-
1958: BURGE H; VANE J R
Method of testing for complete nerve section during vagotomy.
British medical journal 1958;1(5071):615-8.
-
1957: VANE J R
A sensitive method for the assay of 5-hydroxytryptamine.
British journal of pharmacology and chemotherapy 1957;12(3):344-9.
-
1956: MACMILLAN W H; VANE J R
The effects of histamine on the plasma potassium levels of cats.
The Journal of pharmacology and experimental therapeutics 1956;118(2):182-92.
-
1956: DAWES G S; VANE J R
The refractory period of atria isolated from mammalian hearts.
The Journal of physiology 1956;132(3):611-29.
-
1956: BARLOW R B; VANE J R
The ganglion-blocking properties of hexamethylene bisdialkylsulphonium salts.
British journal of pharmacology and chemotherapy 1956;11(2):198-201.
-
1954: VANE J R
Implications of the performance of delinquent girls on the Rosenzweig picture-frustration study.
Journal of consulting psychology 1954;18(6):414.
-
1954: VANE J R; EISEN V W
Wechsler-Bellevue performance of delinquent and nondelinquent girls.
Journal of consulting psychology 1954;18(3):221-5.
-
1953: BORN G V; VANE J R
Gastric secretion induced by histamine.
The Journal of physiology 1953;121(3):445-51.
-
1953: THOMPSON J E; VANE J R
Gastric secretion induced by histamine and its relationship to the rate of blood flow.
The Journal of physiology 1953;121(3):433-44.
-
1953: VANE J R
A new perfusion method.
The Journal of physiology 1953;121(1):97-105.
-
1953: DAWES G S; MOTT J C; VANE J R
The density flowmeter, a direct method for the measurement of the rate of blood flow.
The Journal of physiology 1953;121(1):72-9.
-
1952: BORN G V R; VANE J R
The quantitative determination of diffusible histamine in blood.
British journal of pharmacology and chemotherapy 1952;7(2):298-303.
-
1952: THOMPSON J E; VANE J R
The effect of venous occlusion on arterial blood flow in the extremities; an experimental study.
Surgery 1952;31(1):55-61.
-
1949: Burn J H; Vane J R
The relation between the motor and inhibitor actions of acetylcholine.
The Journal of physiology 1949;108(1):104-15.
Sign-in to see more